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Quantitative DWI as an early imaging biomarker of the response to chemoradiation in
esophageal cancer
By: Benjamin Charles Musall, B.S.
Chair of Advisory Committee: Steven H. Lin, M.D. Ph.D.

For patients diagnosed with stages IIa-IIb esophageal cancer, the current standard of
care treatment is tri-modality therapy (TMT), where neoadjuvant chemoradiation (nCRT) is
followed by surgical resection. Histopathology of resected tumors reveals that pathological
complete response (pCR) is achieved in 20-30% of patients through nCRT alone. Because of
the high mortality and morbidity associated with esophagectomy, it may be advantageous for
patients exhibiting pCR from nCRT alone to be placed under observation rather than
completing their TMT. Therefore, a method for predicting response at an early time-point
during nCRT is highly desirable. Conventional methods such as endoscopic ultrasound, rebiopsy, and morphologic imaging are insufficient for this purpose. During nCRT,
morphologic changes in tumors are often preceded by changes in the tumor biology. Diffusion
Weighed Imaging (DWI) is an MRI modality which is sensitive to microscopic motion of
water molecules in tissue. Quantitative DWI provides a measure of the cellular
microenvironment which is impacted by cellularity, extra-cellular volume fraction, structure
of the extracellular matrix, and cellular membranes. This work sought to investigate if
changes in quantitative DWI may be used as an early imaging biomarker for the prediction of
response to nCRT in esophageal cancer.
DWI scans were performed on a small group of esophageal cancer patients (stages IIa
to IIIb) before, at interim, and after completion of their nCRT. Quantitative diffusion

v

parameter maps were estimated for DWI scans using the following models of diffusion:
mono-exponential, intra-voxel incoherent motion (IVIM), and kurtosis. Summary measures of
quantitative diffusion parameters were extracted from tumor voxels through volumetric
contouring. These summary measures were retrospectively compared between
histopathologically confirmed groupings of patients as pCR and non-pCR. The study found
that the relative change in mean ADC could completely separate groupings of pCR and nonpCR patients (AUC=1) at a cutoff of 27.7%. Measurement by volume contouring was shown
to be highly reproducible between readers. This pilot study demonstrates the promise of using
DWI for organ sparing approaches after nCRT in esophageal cancer.
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Introduction and Background

1.1

Statement of Problem

1.1.1 General Problem
For a majority of cancer, patients undergo clinical management based on their cancer
staging. The staging of the patients typically relies on their clinical status, lab tests, imaging,
and biopsy. The actual treatment regimen is strongly influenced by clinical staging, the site
of the malignancy, and the health of the patient. During the treatment, the patient may be
restaged depending on the response. Because different patients of the same staging may
respond to a treatment differently and every treatment has its toxicity, it is often critical to
characterize individual disease and improve treatment selection on an individual basis.
Evaluating treatment response for individual patients is an essential part of the clinical
management of patients. In particular, prediction of treatment response at an early time point
during therapy would allow for alteration of a patients therapy regimen to minimize the
toxicity and maximize the efficiency of the treatment of the patients.
Cancer therapies, with the obvious exception of surgery, are usually implemented
over a series of weeks. For radiation therapy, a long treatment time is often needed to allow
normal tissues to recover between treatments. For chemotherapy, long treatment times are
needed to achieve the desired malignant cell kill while maintaining toxic chemotherapy
agents at levels acceptable to the patient health. At the end of the therapy regimen, the
response to treatment is often assessed by imaging and the histopathology of surgical
specimens. Whenever available, histopathological metrics are considered a “gold standard”
1

for assessing how well an individual responded to therapy. There are also non-invasive
metrics available after surgery: continued observance of changes in tumor morphology
through imaging and prognostic FDG-PET imaging post-therapy. Although these excellent
prognostic tools are available post-therapy, morphologic measures through conventional
imaging as well as re-biopsy are insufficient for interrogation of patient response early during
therapy. Changes in the tumor microenvironment, which are not visible morphologically,
occur early during therapy. Quantitative Diffusion Weighted Imaging (DWI) provides a
measure of these changes through its sensitivity to diffusion behavior of water molecules in
tissue. Because of this, it may hold value as an early predictor of response.

1.1.2 Specific Problem
For esophageal cancers of stages IIa – IIIb, the current standardized of care is for
patients to treated with neoadjuvant chemoradiation (nCRT), followed by surgical resection
(1). Histopathological metrics post-surgery reveal that 20-30% of patients exhibits pathologic
complete response (pCR) from chemoradiation alone (2-4). Surgical methods for removing
esophageal tumors are highly invasive, with high risk of mortality and morbidity in these
patients (5).
A method of predicting a patient’s response early during their therapy would allow
for pCR patients to forego surgery and instead be placed under observation. Conventional
imaging methods, re-biopsy, and some basic genetic mutation characterization methods have
been found to be insufficient for the purpose of predicting patient response (6-10).
There is an unmet clinical need for a method which can provide an early prediction of
response to chemoradiation in esophageal cancer. Measured changes in intra-tumoral
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diffusion behavior of water molecules during treatment with quantitative DWI may be able to
fulfill this need.

1.2

Esophageal Cancer

1.2.1 Epidemiology
Esophageal cancer is the sixth leading cause of cancer-related mortality worldwide
and its incidence is increasing (11). Overall 5-year survival is under 25%. Esophageal
malignancies are separated into two major histologic groupings based on their tissue type of
origin. Adenocarcinoma (EAC), which originates in esophageal glands, is more common in
North America and Western Europe. Squamous cell carcinoma (ESCC), which originates in
the squamous cells of the epithelium in the esophagus, is more common across Asia, South
America, and southern Africa. A primary risk factor for EAC is high body mass index (BMI)
(12). Due to the endemic of obesity, incidence of EAC is rapidly increasing. Primary risk
factors for ESCC include smoking, poor diet, alcohol consumption (12). Across all
esophageal cancers, incidence is four times more likely in men than in women (12).
Esophageal cancers can also be divided according to the anatomic location of the
disease. The esophagus can be divided into three distinct parts. A diagram of this division
can be seen in Figure 1-1.

3

Figure 1-1: Illustration depicting regions of the esophagus.
For AEC’s, the proximal third and middle third locations account for only a quarter of
the cancers in esophageal cancers, while the remaining cancers are located in the distal third
and gastroesophageal (GE) junction (12). ESCC is more commonly found in the middle
third. Tumor location is important for radiation treatment planning and surgical planning.

1.2.2 Detection and Staging
Esophageal cancer is typically asymptomatic until sufficient tumor growth has
occurred. Because of this, it is usually detected in later stages. Clinical symptoms include
dysphagia (difficulty swallowing) and chest pain. After symptoms are reported, patients are
examined and sent for further tests. Imaging methods used for diagnosing esophageal cancer
include chest x-ray, barium swallow fluoroscopy, contrast CT, and FDG-PET. Once it is
confirmed that the patient has cancer, their cancer is then staged.
4

Staging of esophageal cancer may include information gained from diagnostic
imaging methods (13). It will also include endoscopic ultrasound (EUS) and biopsy. First,
lesion characteristics are used to define the cancer by the TNM system of the American Joint
Committee on Cancer (AJCC). In this system, lesions are given an initial T-stage based on
the degree of their invasion from their site of origin into layers of surrounding tissue. In the
esophagus, T1 implies that the cancer has spread into the epithelium; T2 implies spread into
the muscularis propria; T3 implies that the cancer is growing into the adventitia, and T4
implies local spread to nearby organs. An illustration of these tissue layers is given in Figure
1-2.

Figure 1-2: Layers of the esophagus.
N in TNM represents the relative number of local lymph nodes involved. Further, a
binary M-staging is given, where M0 represents no metastatic spread and M1 represents
metastatic spread. After this, groupings of the cancer are made based on location, TNM
5

staging, and biopsy grading of cell appearance. Stage I patients have no nodal involvement, no
invasion beyond the epithelium, no metastases, and are well differentiated. Stages II-II are
stratified into several levels based on variations of T and N stages as well as tumor location
and cell grading. Stage IV implies metastatic disease.

1.2.3 Treatment Strategy
A treatment course is based on a comprehensive consideration of the initial staging
and the health of the patient. For stage I, surgery is implemented immediately, and is usually
curative (14). For stage IV, palliative treatment is given. For stages IIa through IIIb, the
optimum treatment for patients is trimodality therapy (TMT) (15).

1.2.3.1

Neoadjuvant Chemoradiation Therapy

During TMT, neoadjuvant chemoradiotherapy (nCRT) is used to shrink the tumor and
followed by resection in patients who are healthy enough to be considered for surgery. For
radiation, tumors are irradiated to a total dose of 50.4 Gy (1.8 Gy/frac) over a period of
approximately five weeks (1). Chemotherapy will accompany radiation, consisting of a
combination of cisplatin and either docetaxel or fluorouracil (1). After completion of nCRT,
a patient will undergo surgery. Some patients may be unable to undergo surgery because of
health problems. In this case, their treatment regimen, consisting of only nCRT, is referred to
as bimodality therapy (BMT).

1.2.3.2

Surgical Excision

Surgical resection has shown benefits for locoregional control over definitive
chemoradiation (16). Esophagectomy requires a combined approach towards tumors from
6

both thoracic and abdominal cavities (17). Historically, this was performed through an open
thoracotomy, where an incision is made in the pleural space of the chest (18). More recently,
minimally invasive esophagectomy (MIE) through video-assisted thoracoscopic surgery
(VATS) has become available. MIE does not require a formal pleural incision, and may be
advantageous over open esophagectomy (19). Both techniques requires general anesthesia
and insertion of breathing tubes into the lung. During esophagectomy, a number of adjacent
lymph nodes are also extracted and examined for cancer spread.
Even in experienced centers, post-operative mortality and morbidity from
esophagectomy are in the range of 7-8% (20). This is due to both the radical nature of the
surgery as well as the weakened state of the cancer patients after the chemoradiation.

1.2.4 Evaluation of Treatment Response
1.2.4.1

Post-CRT Methods

Before surgery, a follow-up (FU) FDG-PET scan is taken for the detection of residual
disease, as well as to check for metastatic spread. Qualitative evaluation of FDG-PET scans
after induction chemotherapy has been shown to be highly prognostic of clinical outcome for
both BMT and TMT patients (21).
After surgery, sections of resected tumor are sent to a pathology laboratory and
examined for residual disease. To accomplish this, the resected tissue is formed into slides
and stained with the Hematoxylin and Eosin (H&E) stain. Hematoxylin stains nucleic acids
such as DNA and RNA with a deep blue-purple color, and Eosin is a non-specific stain
which labels proteins with a light pink. This H&E staining method is considered a gold
standard for the examination of cancer histopathology (22). In this presentation, trained
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experts in histopathology can discern cellular structures within the resected tissue. For the
purpose of evaluating residual disease status, histopathologists will search H&E stained
slides for cancer cells and cancer structures which have survived treatment. Several methods
of grouping patients by their post-treatment pathology, or restaging, have been presented in
literature (23). An early grouping method was described for esophageal cancer by Mandard
et al. and is based on a qualitative assessment of surviving cancer cells (24). Visual depiction
of these groupings and their descriptions can be seen in Figure 1-3.

Figure 1-3: Tumor Regression Grades by Mandard grouping depicted as illustrations.
In the Mandard method, patients are placed in tumor regression groups based on
subjective qualitative measures. At MDACC, an quantitative adaptation of the Mandard
method known as the four-tiered grading system is used (25). In this method, a term called
viable cell percentage is derived by comparing of the relative areas occupied by cancer cells
and normal tissue. In the four-tiered system, TRG1 corresponds to 0% viable cancer cells or
pathologic complete response (pCR). TRG2 corresponds to measures of tumor cells between
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<1% to 10% viable cells. TRG3 corresponds to >10% to 50% viable cancer cells, and TRG4
corresponds to >50% viable tumor cells.

1.2.4.2

Early Prediction of Response

Previously, several possible methods of predicting response of esophageal therapy
during nCRT have been examined. Endoscopic US combined with biopsy has been shown as
insufficient for predicting pCR (6, 7). A potential reason is that morphologic changes visible
with US may not be present at an early time-point during therapy, and biopsy is always
limited by its sampling errors. Likewise, CT and T2-weighted MR imaging are not able to
predict response (26). Genetic characterization has shown minor successes (8-10) but does
not yet have the sensitivity needed to predict pCR. Quantitative FDG-PET has also shown
some success (7, 27), but is difficult to measure during therapy because of non-specific
uptake caused by radiation induced inflammation. FDG-PET results may improve in future
studies due to improved protocol design and improved methods for acquiring FDG-PET
parameter summary measurements.
Multi-parametric MRI is being investigated for predicting therapy response in cancers
with increasing frequency and varying success (28). In a previous study, quantitative
diffusion MRI has demonstrated excellent sensitivity to pCR (29). The protocols within this
thesis were designed, in part, as a validation of this previous study by Van Rossum et al.
Dynamic Contrast Enhanced (DCE) MRI has also been shown to have value for response
prediction (30), but suffers from poor reproducibility.
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1.3

Magnetic Resonance Imaging
This purpose of this section is two-fold. The first is to demonstrate an understanding

of MRI from a fundamental level. The second is to later extend these fundamental
explanations to the more specific and advanced MRI methods used in the MRI research
protocols of this thesis.

1.3.1 Basic Principles of MRI
1.3.1.1

Behavior of Protons in a Magnetic Field

For atomic isotopes with an odd number of nucleons, the net angular momentum of
the system is non-zero. In the case of protium (1H), the contribution of a single proton creates
a net angular momentum or “spin” of +/- ½. When a proton is placed in an external magnetic
field, this non-zero spin will align with the direction of the external magnetic field and
precess about this direction. The frequency of precession is referred to as the Larmor
frequency, and it is dependent on both the strength of the external magnetic field (B0) as well
as the intrinsic gyromagnetic ratio of the proton (42.58 MHz/T). This relationship is
described in the Larmor equation:
Equation 1: 𝝎𝟎 = 𝜸𝑩𝟎
where ω0 is the Larmor frequency, γ is the gyromagnetic ratio, and B0 is the external
magnetic field strength.
In a group of protons, not all of the protons will align with the magnetic field
(parallel). A slightly smaller amount of them will align in the direction opposite the external
magnetic field (anti-parallel). At 25̊ C, thermal energy is sufficient to induce changes
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between these two quantum states in individual proton spins. Despite this, a sufficiently large
group of protons will always have slightly more spins in the parallel state, creating a bulk
magnetization. This magnetization is proportional to B0 and inversely proportional to
temperature. This relationship is described through combination of a Maxwell’s Laws and a
Boltzmann distribution in Equation 2:

Equation 2: 𝑴𝟎 =

𝝆𝟎 𝜸𝟐 ℏ𝟐
𝟒𝒌𝑻

𝑩𝟎

where M0 is the net magnetization per unit volume, ρ0 is the density of protons, γ is the
gyromagnetic ratio, ћ is the Planck’s constant, k is the Boltzmann constant, T is temperature,
and B0 is the external magnetic field. In MRI, B0 refers to the static magnetic field. This net
magnetization is depicted in Figure 1-4.

Figure 1-4: Diagram indicating excess alignment of spins with B0 to form the net
magnetization M0. Conventional designation of Cartesian dimensions is also shown.
The high density of water protons in vivo combined with high magnetic field
strengths in clinical MRI scanners create a relatively large bulk magnetization in tissue. This
bulk magnetization and its properties are used for imaging with MRI.
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1.3.1.2

Bloch Equations

The group behavior of spins or bulk magnetization can be derived from Maxwell’s
laws, and were first described mathematically by Felix Bloch in 1946 (31). Behavior of bulk
magnetization in the presence of external magnetic fields can be described through the Bloch
equation:

Equation 3:

⃑⃑⃑ (𝒕)
𝒅𝑴
𝒅𝒕

⃑⃑⃑ (𝒕) × 𝑩
⃑⃑ 𝒆𝒙𝒕 −
= 𝜸𝑴

𝑴𝒕𝒓𝒂𝒏𝒔𝒗𝒆𝒓𝒔𝒆
𝑻𝟐

−

𝑴𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍 − 𝑴𝟎,𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍
𝑻𝟏

where M(t) is the time-variant magnetization of the sample, γ is the gyromagnetic ratio, Bext
is the vector of combined external magnetizations, Mtransverse is the magnetization of the
sample transverse to B0, T2 is the spin-spin relaxation constant, Mparallel is the magnetization
of the sample parallel to B0, and T1 is the spin-lattice relaxation constant. Spin-spin
relaxation, or T2, refers to dephasing of spins in the transverse plan by exchange of angular
momentum between spins through dipole-dipole interactions, variations in the local magnetic
fields, and other interactions (32). As implied in the combined Bloch equation, T2 relaxation
through gradual misalignment of individual spins results in an exponential decay of
Mtransverse. T2 is also affected by B0 inhomogeneities, which result in a shorter apparent T2
relaxation time referred to as T2*. Separately, T1 relaxation refers to the exponential recovery
of Mparallel as magnetization returns from an excited state to its steady state alignment with B0.
Both T2 and T1 relaxations create exponential decay of the transverse net magnetization. T2
refers to the time when 63% of transverse magnetization has been lost to spin-spin relaxation
and T1 refers to a time where 63% of the magnetization has realigned with B0. In tissue, these
relation times are variable between tissue types. This variation in relaxation times between
tissues is used as a source of contrast in anatomic imaging.
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By selecting a time of measurement which maximizes the difference in transverse
magnetization between tissues of differing T1 or T2, a weighted contrast can be optimized for
the image. For individual tissues, T1 is always longer than T2. Thus, relatively short
measurement times (echo time, TE) with little recovery between measurements (repetition
time, TR) produce greater emphasis on T1 differences and are considered T1-weighted.
Conversely, relatively long TE and long TR emphasize T2 differences and considered T2weighted. Short TE and long TR minimize effects of both T1 and T2 relaxations on
measurement, and give way to a proton density weighting of measurements.

1.3.1.3

Signal Generation

To detect the bulk magnetization of protons in a magnetized sample, the
magnetization must be re-oriented into the transverse plane. This may be accomplished
through the application of an oscillating secondary magnetic field, B1. In MRI, this B1 field
must oscillate with a frequency equal to Larmor frequency of protons within the B0 field. At
the B0 strength of a clinical MRI scanner, an oscillating magnetic field of this frequency falls
within the range of the electromagnetic spectrum corresponding to radio waves. Because of
this, B1 fields are also referred to as a radiofrequency (RF) pulse. The force imparted from a
B1 field transverse to B0 can be used to nutate the net magnetization of the sample into the
transverse plane. The angle of this nutation or flip is dependent on the magnitude and
duration of the RF pulse, as shown in Equation 4:
Equation 4: ∝= 𝜸 ∫ 𝑩𝟏 (𝒕)𝒅𝒕
where α is the flip angle, γ is the gyromagnetic ratio, and B1 is the magnitude of the RF
pulse. A pulse which tips magnetization from its steady state alignment with B0 into the
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transverse plane is referred to as an excitation pulse. If the magnetization is left undisturbed
after its excitation, an exponential decay of its transverse component called Free Induction
Decay (FID) will occur by T2* relaxation.
Through an interaction described by Faraday’s Law, the transverse magnetization
induced emf or an electric current in orthogonally placed conducting loops. In MRI, these
conducting loops are known as receiver coils. Although receiver coils are more sensitive to
nearby changing magnetization in accordance with the inverse square law, they are unable to
fully spatially localize spins. Thus, a technique for spatially encoding spins into received
signal must be utilized.

1.3.1.4

Location Encoding

The addition of spatially variant magnetic fields is used to localize magnetization in
MR imaging. In Cartesian imaging, localization must be accomplished in three dimensions.
While the direction of these dimensions is arbitrary and may be altered to better portray
certain anatomies, a majority of MRI acquisitions are taken as axial images. For localization
in axial imaging, the three spatial dimensions may be separated into two types: the dimension
which is parallel to the B0 field (the z-axis, by convention) and the two dimensions of the
transverse plane (x-y plane, by convention).
Localization along the z-axis is also known as slice selection. For visualization of
axial images, variations in signal are displayed on the transverse plane or “slice”, while the zaxis is implicit and unseen dimension corresponding to the thickness of the visualized
anatomy. A technique for selection of a slice of certain location and thickness was first
described by Peter Mansfield in the 1970’s (33). The desired thickness and location of a slice
is selected during excitation with the addition of a gradient field Gz, which creates a linear
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variation in the Larmor frequency along the z-axis. A slice of spins may be selectively
excited using an RF pulse whose central frequency and bandwidth are limited to the Larmor
frequency range present within spins of the desired slice. This relation is detailed in Equation
5:
Equation 5: 𝑩𝑾𝑹𝑭 = 𝜸𝑮𝒁 ∆𝒛
where BWRF is the frequency bandwidth of the RF pulse, γ is the gyromagnetic ratio, Gz is
the slice selection gradient, and Δz is the thickness of the sample intended for excitation. In
this equation, it is implied that the central frequency of the RF pulse corresponds to the
Larmor frequency of spins centered in the z-dimension of the slice. This process of slice
selective excitation may by reapplied if multiple RF pulses are used sequentially. A visual
illustration of slice selective excitation can be seen in Figure 1-5.

Figure 1-5: Slice selection through application of magnetic field gradient in combination
with a selective bandwidth (W) RF pulse.
Although encoding in the transverse dimensions is also accomplished with spatially
varying magnetic fields, their implementation is different. Unlike slice selection, the two
transverse dimensions are encoded directly into the signal which is read-out by the receiver
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coils. The two linear magnetic fields, Gx and Gy, do not isolate signal from a specific point
within the imaging plane. Rather, these gradients produce spatial variations in the
contribution of all excited spins. Transverse gradients are used to create spatial variation of
magnetic field across the transverse dimension, which produces spatial variation in the
Larmor frequency of spins. Over the duration of the gradient, the variable spin frequencies
will result in spatially varying directionality of magnetization. This may also be referred to as
an accumulation of phase. The amount of phase accumulated during the application of the
gradient is dependent on the position of the spin as well as the magnitude and duration of the
gradient. This is described mathematically by Equation 6:
Equation 6: 𝜽 = 𝜸 ∫ 𝑮𝒙 (𝒙, 𝒕)𝒙𝒅𝒕
where θ is the accumulated phase, γ is the gyromagnetic ratio, Gx(x) is the strength of the
gradient at location x, and x is the location of the spin.
Because phase is periodic, its variation will occur cyclically along the direction of the
gradient. This phenomenon is better known as spatial frequency, with units of inverse unit
length. The spatial frequency in spins produced through application of a gradient field is
described in Equation 7:
Equation 7: 𝒌 = 𝜸 ∫ 𝑮(𝒕)𝒅𝒕
where k is the spatial frequency, γ is the gyromagnetic ratio, and G is the magnitude of the
gradient. During an acquisition, information will be sampled using spatial frequencies of
varying magnitude and direction across the transverse plane. The signal collected from this
acquisition can be plotted in k-space, which is the conjugate of image space. A comparison
of these spaces can be seen in Figure 1-6.
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Figure 1-6: Image space and k-Space of a T2-weighted image of a human thorax.
By using the inverse Fourier transform to change the dimensionality of the data, the
k-space acquisition may be converted into image space. The Fourier relationship between kspace and image space is described by Equation 8:
Equation 8: 𝑺(𝒌𝒙 , 𝒌𝒚 ) = ∬ 𝝆(𝒓)𝒆−𝒊𝟐𝝅(𝒌𝒙 𝒙+𝒌𝒚 𝒚)
where S(kx,ky) is the distribution of signal in k-space, ρ(r) is the spatial distribution of spins
or proton density, kx/ky are the Cartesian coordinates of different spatial frequencies in kspace, and x/y is the location of spins in Cartesian image space. The central area of k-space
(near the origin) contains information on low spatial frequencies of the system. It serves as
the primary source of image contrast and has a relatively high signal. The outer section of kspace contains information on higher spatial frequencies. It has relatively small signal, and its
extent determines the spatial resolution of an image.
In conventional MRI, filling k-space can be more efficiently accomplished by
continuous readout along one dimension (referred to as frequency encoding) and stepped
along another (phase encoding). By convention, the x-direction is typically considered as the
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frequency encoding direction, while the y-dimension is typically considered the phase
encoding dimension. A gradient pulse diagram and k-space trajectory of this conventional
acquisition method can be seen in Figure 1-7.

Figure 1-7: Gradient encoding of 2D Fourier data as a both gradient waveform and as a
k-space trajectory. Phase encoding is shown in orange, and frequency encoding is shown
in green.

1.3.1.5

Basic Pulse Sequences

In MRI, two basic pulse sequences underlie most of clinical imaging: spin-echo (SE)
and gradient-echo (GE). The GE pulse sequence uses the FID signal for spatial encoding. In
contrast, the SE pulse sequence uses the spin echo signal from the application of an
excitation/refocusing RF pulse pair for spatial encoding.
In spin-echo sequences, a second RF pulse (B1) is applied to the spins with a flip
angle of 180̊. This 180̊ pulse is typically applied orthogonally to both the B0 field and the
excitation pulse. The 180̊ pulse flips the spins in the transverse plane to their conjugate
direction so that dephasing of different spins due to B0 inhomogeneities is reversed. This
rewinds the phase evolution of the spins to form coherent signal in the form of an echo.
Because the dephasing effects of B0 inhomogeneities are reversed, the observed T2 contrast at
the echo is attributable to T2 alone rather than T2*. It is advantageous to select a flip angle of
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90̊ for SE because it maximizes the signal. A pulse sequence diagram for a typical SE
sequence with conventional location encoding can be seen in Figure 1-8.

Figure 1-8: A typical SE sequence. The pulse sequence, gradient waveform, and readout
signal are shown.
For GE, a true echo is not formed. Instead, a bipolar gradient is used to form a fast
dephasing and rephasing of spins, during which transverse magnetization behaves similarly
to an echo. The first lobe of the bipolar gradient dephases the spins by a known amount and
the second opposing lobe of the gradient rephases the spins to create the “echo”. Because the
effects of B0 inhomogeneities are not reversed, the signal amplitude GE sequence decays
with T2*. GE imaging does not require a 90̊ flip angle for the initial excitation pulse,
allowing for selection of a flip angle which is optimized by application and anatomy of
interest. A pulse sequence diagram for a typical GE sequence with conventional location
encoding can be seen in Figure 1-9.
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Figure 1-9: A typical GE sequence. The pulse sequence, gradient waveform, and readout
signal are shown.
Pulse sequence selection is application dependent. For T2-weighted imaging, SEbased sequences are favorable because they can remove T2* effects from contrast. GE
imaging is useful for fast T1-weighted imaging because of short TR and low flip angle. These
are generalizations for the basic forms of these pulse sequences. Advanced methods of
applying SE and GE have been developed which defy the limits of their general forms and
extend their usefulness. For diffusion imaging, both may be used, but SE is favored for
reasons described in the following section.

1.4

Diffusion Weighted Imaging

1.4.1 Diffusion Behavior
1.4.1.1

Idealized Diffusion by Random Brownian Motion

Diffusion refers to the random Brownian motion of particles driven by entropy and
thermal energy. It was first described mathematically by Adolf Fick (34), who presented
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diffusion as random movement of a species along a concentration gradient. This formulation
is shown in Equation 9:

Equation 9:

𝒅𝒄𝒊
𝒅𝒕

= 𝑫𝒊 𝛁 𝟐 𝒄𝒊

where ci is the concentration of a molecular species within a medium and D is the diffusion
coefficient with units of length squared over time. With the assumption of Gaussian diffusion
behavior, the diffusion coefficient can be more simply explained with Albert Einstein’s
derivation in Equation 10:

Equation 10: 𝑫 =

<𝒙𝟐 >
𝟐𝒕

where D is the diffusion coefficient from Fick’s Law, <x2> is the 1D mean-squared
displacement of the particle from its original position, and t is the length of time over which
the particle diffused. For a particle of water in a homogenous water medium at a typical
human body temperature (37̊ C), the diffusion coefficient would be approximately 1 x 10-3
mm2/s (35). Solution of Equation 10 shows that if a water molecule was allowed to diffuse in
these conditions for 100 ms, it would travel an average of 25 μm from its original position. It
can be seen in this derivation, that for a particle with a given diffusion coefficient, diffusion
over a certain time scale corresponds with a certain “length-scale”.
Einstein further described the diffusion coefficient in his Ph.D. thesis through the
Stokes-Einstein equation for 3D diffusion of spherical particles in a medium. This is shown
in Equation 11:

Equation 11: 𝑫 =

𝑹𝑻

𝟏

𝑵𝒂 𝟔𝝅𝜼𝒂 𝒓

21

where D is the diffusion coefficient, R is the gas constant, T is the absolute temperature, Na is
Avogadro’s number, ηa is the viscosity of the solvent, and r is the radius of the particle. This
equation implies that the diffusion coefficient of a spherical particle is dependent on three
variables: temperature, particle size, and the viscosity of the solvent.

1.4.1.2

Diffusion in Tissue

In tissue, temperature is constrained to its range within the human body, which is not
highly variable in term of absolute temperature. Particle size and shape are constricted to that
of water. Although MRI is also sensitive to magnetization of fat, efforts are taken to remove
fat contribution to signal from the contribution of water in DWI. This leaves the viscosity as
the major impactor of the diffusion coefficients in MRI measurements of diffusion. However,
the Stokes-Einstein equation is limited to systems of quiescent and homogenous fluid.
Biological tissue satisfies neither of these assumptions.
The assumption of quiescence fails due to perfusion and bulk motion of water
molecules in tissue. These perfusion effects occur on larger length-scales than pure diffusion,
but are important in MRI measurement of diffusion. The assumption of homogeneity fails
because of the varied makeup of biological tissue. Water molecules exists in a biological
solvent of heterogeneous composition. While moving, these water molecules also may
encounter barriers such as cellular membranes, organelle membranes, large macromolecules,
and components of the extra-cellular matrix (ECM). Because of this, the diffusion coefficient
of water in tissue is a product of complex set of interactions between water molecules and
various organic structures. Previously, MRI measurements of diffusion in tissue has been
shown to relate to cellularity (36), ECM composition (37), extracellular volume fraction
(ECVF) (38), and membrane permeability (39). Historically, measurement of diffusion
22

coefficient by MRI rose in popularity because the diffusion coefficient is able to detect stroke
and classify it by type after the stroke occurs (40).

1.4.1.3

Diffusion in Cancer

In cancerous tissues, rampant uncontrolled cell growth leads to high cellularity within
tumors. This, among other possible factors, leads to lower mobility of water in malignant
tissue and a lower diffusion coefficient in malignant tissue. An illustration showing restricted
diffusion can be seen in Figure 1-10.

Figure 1-10: Illustrations depicting movement of water molecules within tissues of
varying cellularity. The blue line represents the random movement of a water molecule
while the black circles represent cells. Republished with permission (License ID =
4167471220873 from ww.copyright.com) from original article: O'Flynn, E. A. M., and N.
M. deSouza. 2011. Functional magnetic resonance: biomarkers of response in breast
cancer. Breast Cancer Research : BCR 13: 204.
Because of this phenomena, images with diffusion-based contrast as well as estimated
maps of the diffusion coefficient are able to delineate cancer and normal tissue. This has been
used for detection (41-43), T-staging (44), and N-staging (45) for a variety of cancers.
This project is focused on changes in diffusion throughout therapy. In tumors treated
with conventional therapies such as chemotherapy and radiation (and some other therapies),
water mobility increases after treatment (26). It has been shown in several anatomic sites that
changes in diffusion at an early time-point during treatment are different between patients
who exhibit good response to treatment and patients who exhibit poor response to treatment
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(29, 46-48). Patients exhibiting good response to therapy show a larger relative increase in
water mobility in comparison to patients with partial or poor response to therapy.

1.4.2 Diffusion Sensitization and Contrast in MRI
The effects of diffusion are ever present in MRI images. This is because T2 relaxation
is partially mediated by diffusion. Diffusion weighted imaging (DWI) describes MRI pulse
sequences and acquisition methods which attempt to isolate diffusion as a contrast
mechanism. The Bloch equation (Equation 3) has previously been extended by H.C. Torrey
using Fick’s Law (Equation 9) to include the effects of diffusion (49). The Bloch-Torrey
formulation is shown below in Equation 12:

Equation 12:

⃑⃑⃑ (𝒕)
𝒅𝑴
𝒅𝒕

⃑⃑⃑ (𝒕) × ⃑𝑩
⃑ 𝒆𝒙𝒕 − 𝑴𝒕𝒓𝒂𝒏𝒔𝒗𝒆𝒓𝒔𝒆 − 𝑴𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍 − 𝑴𝟎,𝒑𝒂𝒓𝒂𝒍𝒍𝒆𝒍 + 𝑫𝛁 𝟐 ⃑𝑴
⃑⃑ (t)
= 𝜸𝑴
𝑻
𝑻
𝟐

𝟏

where M(t) is the time-variant magnetization of the sample, γ is the gyromagnetic ratio, Bext
is the vector of combined external magnetizations, Mtransverse is the magnetization of the
sample transverse to B0, T2 is the spin-spin relaxation constant, Mparallel is the magnetization
of the sample parallel to B0, T1 is the spin-lattice relaxation constant, and D is the diffusion
coefficient. If relaxation terms are neglected, only transverse magnetization is considered,
and only gradient fields are accounted for, Equation 13 will result:

Equation 13:

⃑⃑⃑ (𝒓
⃑ ,𝒕)
𝒅𝑴
𝒅𝒕

⃑⃑⃑ (𝒓
⃑⃑⃑ (𝒓
⃑ ∙ ⃑⃑⃑⃑⃑⃑⃑⃑⃑
⃑ , 𝒕) + 𝑫𝛁 𝟐 𝑴
⃑ , 𝒕)
= −𝒊𝜸(𝒓
𝑮(𝒙))𝑴

where M(r,t) is the time and space dependent magnetization of the sample, γ is the
gyromagnetic ratio, the vector r is the spin location, G(x) is the external gradient as a
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function of location, and D is the diffusion coefficient. For the case in which D=0, integration
of Equation 13 will result in Equation 6.
The method of diffusion sensitization which is used in MRI was initially
demonstrated by E.O. Stejskal and J.E. Tanner in an NMR experiment (50). Their method
takes the form of a pair of pulsed gradients (known as Stejskal –Tanner gradients) the first of
which encodes spin location with dephasing throughout the sample and the second of which
provides the opposite location-based rephasing, forcing realignment of non-moving spins.
Spins that experience these gradients at different positions will not experience complete
rephasing. This causes dephasing of the spins and a loss of signal in areas where spins are
mobile. The pulsed gradient SE (PGSE) implementation of Stejskal-Tanner gradients as well
as an illustration of its effects on moving and non-moving spins can be seen in Figure 1-11.

25

Figure 1-11: Pulse sequence and simplified gradient waveform for a PGSE sequence. The
gradient duration is labeled with δ, and the time elapsed between gradient is labeled with
Δ. At the bottom, an illustration is shown comparing dephasing and rephasing effects on
the magnetization of moving (red) and non-moving (blue) spins.
The effects of these diffusion sensitization gradients on MR signal can be desscribed
through further derivation of Equation 13. Stejskal and Tanner used bounds imposed by their
pulsed gradient experiment to derive a mono-exponential model of diffusion from the BlochTorrey equation, which is shown in Equation 14.
𝑺

Equation 14: 𝑺 = 𝒆−𝑫∗𝜸

𝟐 𝑮𝟐 𝜹𝟐 (∆−𝜹)
𝟑

𝟎

where S is the signal level of the diffusion images, γ is the gyromagnetic ratio, G is the
magnitude of a single gradient, δ is the duration of a single gradient pulse, and Δ is the time
lapse between the pulsed gradients. This derivation shows that the degree of signal loss is
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dependent upon several variables. The variable of interest is the diffusion coefficient of the
tissue. The remainder of the variables affecting the degree of signal loss include the strength
of the location encoding gradients (magnitude), the duration of the location encoding pulse,
and the time between the pulses (during which spins are allowed to move). These variables
are grouped into a single parameter known as the b-value (alternatively as the b-factor). The
formulation for the b-value is shown in Equation 15:
𝜹

Equation 15: 𝒃 = 𝜸𝟐 𝑮𝟐 𝜹𝟐 (∆ − 𝟑)
where γ is the gyromagnetic ratio, G is the magnitude of a single gradient, δ is the duration of
a single gradient pulse, and Δ is the time lapse between the pulsed gradients. Diffusion
images acquired with a certain b-value are referred to by bVALUE (Ex: Images acquired at b
= 200 s/mm2 are referred to as b200 images). The maximum b-value an MRI scanner can
produce with constant Δ is limited by its gradient hardware. It should be noted that identical
b-values might be achieved with different combinations of gradient pulse areas, gradient
pulse durations, and diffusion times. For the purposes of the experiments in this thesis, bvalue is assumed to be the only technique factor impacting signal, although this is not
necessarily true (51).
Other sources of contrast are minimized in diffusion scans by maintaining TE and TR
across diffusion images with different b-values. This helps to minimize deviation from the
assumptions made in Equation 13.
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1.4.3 Models of Diffusion in MRI
1.4.3.1

Mono-Exponential Model

The simplest model of diffusion, the mono-exponential model (Equation 14), is the
product of direct derivation of the Bloch-Torrey equation. Even if anatomic motion is
ignored, the diffusion coefficient from this equation is the result of a complex combination of
spin motion phenomena which are interrogated with Stejskal-Tanner gradients. In
acknowledgement of these complex phenomena underlying this measurement, the monoexponential diffusion coefficient is referred to as the apparent diffusion coefficient (ADC).
Violations of the assumptions used to derive Equation 14 may be included in more
complex diffusion models. This is done both for the purpose of better estimating the true
diffusion coefficient as well as identifying other factors affecting diffusion contrast separate
from initial assumptions. In order to separate these other factors from the diffusion
coefficient, b-values must be chosen which characterize spin motion on two separate ranges
length-scales. These two ranges of b-values must be chosen so that in one range, the
diffusion coefficient is the dominant contrast mechanism and in the other range, signal levels
are impacted by both the diffusion coefficient and the other factor. Mathematical
comparisons of signals over these two range of b-values will then allow for isolation of the
diffusion model parameters. At low b-values, perfusion of microvasculature causes a
deviation from mono-exponential diffusion behavior shown as signal loss beyond that
expected of diffusion alone. At high b-values, deviations from the assumption of Gaussian
diffusion, or kurtosis, cause an opposite deviation in signal where measured signal is higher
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than what is expected from diffusion alone. A plot detailing these effects can be found in
Figure 1-12.

Figure 1-12: Graphical depiction of deviations in signal levels due to perfusion effects
(red) at low b-values and from kurtosis effects (green) at high b-values.

1.4.3.2

Intra-voxel Incoherent Motion Model

In the case of lower b-values (tissue dependent, typically in the approximate range of
0 to 300 s/mm2), larger length-scales of motion are interrogated and signal loss is due to a
combination of diffusion and perfusion effects. Perfusion stems from microcirculation in
capillaries within a given voxel, and is the dominant mechanism of signal loss in this range
of b-values. Signal loss from perfusion will reach a limit, and at higher ranges of b-values
will not further impact signal loss. A modeling method for perfusion effects, originally
described by Denis Le Bihan, is the intra-voxel incoherent motion (IVIM) model (52). In this
model, it is assumed that the orientation of capillaries within a given voxel is random, and
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movement of fluids through these voxels mimics the random motion of diffusion on a larger
length-scale. A visual depiction of this random capillary orientation can be seen in Figure
1-13.

Figure 1-13: Random orientation of capillaries within a hypothetical voxel of tissue.
Republished with permission (License ID = 4167550994385 from ww.copyright.com)
from original article: Malyar, N. M., M. Gossl, P. E. Beighley, and E. L. Ritman. 2004.
Relationship between arterial diameter and perfused tissue volume in myocardial
microcirculation: a micro-CT-based analysis. American journal of physiology. Heart and
circulatory physiology 286: H2386-2392.
On this basis, contribution of perfusion motion to signal loss may be simply modeled
as a second exponential, whose contribution to signal loss is limited to a maximum effect
reached at low b-values. This IVIM model is stated in Equation 16.
𝑺

∗

Equation 16: 𝑺 = (𝟏 − 𝒇)𝐞−𝐛∗𝐃 + 𝒇𝒆−𝒃∗𝑫
𝟎

where f is the perfusion fraction, D is the true diffusion coefficient, and D* is the pseudodiffusion coefficient representing the b-value dependent contribution of perfusion to signal
loss. In general, this D* coefficient is an order of magnitude larger than D coefficient (52).
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This model has been used for application in cancer with varying success (43, 53, 54).
When selecting b-values for this exam, it is important to select multiple low b-values to fully
characterize the perfusion effects on signal loss (55).

1.4.3.3

Diffusion Kurtosis Model

When diffusion is probed on a small length-scale, barriers such as cell membranes
pose a greater effect on the diffusion probability distribution (Equation 10) of water
molecules. This is because these barriers block a significant portion of nearby space (relative
to length-scale). The presence of barriers of any shape will alter the diffusion probability
function so that shorter diffusion lengths are more likely. This is a violation of the
assumption of Gaussian diffusion behavior, and results in a compression of the ideal
Gaussian distribution of the diffusion probability density function. This means reducing the
probability of values in the tails and increasing the probability of values close to the mean, as
shown in Figure 1-14.
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Figure 1-14: Depiction of probability function distributions with differing kurtosis. The
kurtosis observed in diffusion is positive, which is depicted as a change in the probability
density function from the red plot to the green plot.
This change in the distribution of the diffusion probability function can be described
as a Gaussian function altered with a kurtosis parameter (56). The kurtosis of a distribution is
the fourth moment mathematically, and it can be calculated for diffusion using Equation 17:

Equation 17: 𝒌(𝒙) =

𝝁𝟒
𝝈𝟒

=

<(𝒏∙𝒔)𝟒 >
<(𝒏∙𝒔)𝟐 >𝟐

where k is the kurtosis parameter, μ is the average diffusion distance, σ is the standard
deviation of the probability function, n is the unit vector and s is the diffusion distance
vector. If this kurtosis term is incorporated in the derivation of Equation 14, Equation 18 will
result (56):
𝑺

𝟏 𝟐
𝑨𝑫𝑪𝟐 𝒌

Equation 18: 𝑺 = 𝒆−𝒃∗𝑨𝑫𝑪+𝟔𝒃
𝟎

Examination of this equation shows an intuitive mathematical relationship between
signal levels and the kurtosis effect. As length-scale is decreased (b-value increases), the
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effects of kurtosis (barriers blocking diffusion) is increased (second order relationship to bvalues). This reduces signal loss from diffusion, as molecules are less likely to diffuse as far.
This can be seen in Figure 1-12, where kurtosis effect is evident at higher b-values (1000
s/mm2 and upwards). Measurement of the kurtosis parameter is shown to be useful for
various applications in cancer at several anatomic sites (57-59).

1.4.4 Advanced MRI Techniques for DWI
Many advanced MRI techniques have been developed and implemented since the
birth of MRI. This section aims to explain a few important techniques which have been used
in this project and are essential for clinical implementation of DWI. Several of these
techniques provide acquisition acceleration. This acceleration serves to improve
reproducibility and image quality of diffusion images and lower scan times. Another
important technological development is the increase of gradient strength. As recently as 25
years ago, maximum b-values achievable on a clinical scanner were on the order of 200
s/mm2 (51). The development of these techniques and gradient technology has been essential
for clinical implementation of fast and reproducible diffusion imaging.

1.4.4.1

Echo Planar Imaging

Echo Planar Imaging (EPI) was first described by Peter Mansfield in 1977 (60). EPI
is an acquisition in which all or most of k-space is collected in a single TR. Single-shot EPI
(ssEPI) describes EPI in which the entirety of k-space is collected in one TR, whereas multishot EPI describes the acquisition of k-space within a few TRs. Within this paper, all DWI
images were taken using ss-EPI techniques. The standard method of covering k-space is a
raster navigation, where lines of k-space are acquired in a back-and-forth scanning trajectory.
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In this method, Gx (which is referred to as the frequency encoding gradient in EPI) is used to
provide continuous back-and-forth movement between the edges of k-spaces. Gy (referred to
as the phase encoding gradient in EPI) is blipped to switch between phase encoding lines.
The EPI acquisition is typically centered on the echo, so that the center of k-space is acquired
with maximum signal. A diagram of k-space navigation by this method and the EPI gradient
waveform can be found in Figure 1-15.

Figure 1-15: EPI k-space trajectory where the phase encoding direction is blipped, and
the frequency encoding direction is continuous.
EPI offers several advantages over conventional imaging, especially for DWI. The
speed of imaging offered by EPI minimizes readout time and nearly eliminates motion
artifacts. EPI also is advantageous for DWI because it enforces consistency in TE/TR across
diffusion images, minimizing sources of contrast besides spin mobility.
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1.4.4.1

Multi-slice Acquisition

Multi-slice acquisition uses composite RF pulses to excite multiple slices
simultaneously. A delay is introduced in between excitation of different slices to create a
phase difference in excited signal of different slices. These signals can then be separated in
post-processing of the acquired signal to create images of separate slices (32). Because
multiple slices can be acquired simultaneously, the scan time of sequences can be greatly
reduced.

1.4.4.2

Parallel Imaging

Parallel imaging is a technique which accelerates acquisition by taking advantage of
redundancy in k-space. In this technique, k-space is symmetrically under-sampled in the
phase encoding direction. This under-sampling results in a reduced field of view (FOV) in
uncorrected images, which is accompanied by wrap-around aliasing artefacts. Parallel
imaging uses sensitivity maps from receiver coils as a separate source of location information
to resolve aliasing and geometric distortion, as well as restore FOV. This correction may be
applied through different techniques in both image space and k-space. Notable methods of
performing these corrections include SENSE (61) and GRAPPA (62). Parallel imaging
typically provides acquisition accelerations on the order of 2-4x.

1.4.4.3

2D Selective RF Excitation

A more recently developed technique utilized in the experiments of this thesis is 2D
selective RF excitation by the method of Saritas et al. (63). Several methods of 2D RF
excitation have been described previously, but this particular technique is superior because of
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its compatibility with adjacent slice multi-slice acquisition. In this technique, an echo-planar
blipped RF is applied within “excitation k-space” to excite a 2D slab of tissue. Excitation kspace is analogous to image space in the frequency encoding or slice selection direction and
cyclic in the phase encoding or slab selection direction. The phase encoding direction of
excitation k-space creates a phase separation of water and fat due to chemical shift as phase
evolves during the excitation period.
This technique is advantageous for several reasons. The primary reason is because it
is able to reduce the number of phase encoding lines during excitation without compromising
the resolution. Shortened EPI readout has the benefit of reduced image distortion and
artefacts. This shortened phase encoding direction must be applied on a “short” dimension of
the organ of interest. In the case of tubular organs, such as the spinal cord and esophagus,
two short dimensions are available. Typically, the AP direction is chosen to be shortened
because it is most impacted by breathing motion. The second advantage of this technique is
that it produces an intrinsic water-fat separation during phase encoding of excitation k-space.
Fat separation is important for implementation of DWI, and in DWI scans which do not
incorporate 2D selective RF excitation, other methods must be utilized to remove fat
contribution from signal.
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1.5

Hypothesis
Two-week changes in quantitative DWI parameters are predictive of the response to

neoadjuvant chemoradiation in esophageal cancer.

1.6

Specific Aims
Specific Aim I: To determine how early changes in DWI parameters in patients of

esophageal cancer treated with chemoradiation correlate with measures of clinical outcome.
Specific Aim II: To evaluate reproducibility of ADC measurements between readers
for both volumetric and slice contouring methods.
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2

Materials and Methods

2.1

Patient Selection and Outcome Measures
Patients afflicted with esophageal cancer between stages IIa and IIIb were enrolled

into this ongoing prospective study starting in 2014. These patients were given standard of
care treatment in the form of nCRT followed by surgical resection. Histopathologic analysis
of resected tissue provided measures of % viable cells. Based on this measure, patients were
classified into TRG’s according to the four-tier grading system. Disease progression after
surgery was also tracked through follow-up for the purpose of eventual analyses of survival.
Patients who deviated from the study protocol were considered inevaluable, and
additional patients were enrolled. This study was approved by the MDACC IRB and patient
consent was obtained in all cases.

2.2

MRI Scan Protocols
MR exams for each patient were performed at three points along the course of nCRT:

before nCRT at baseline (BL), two-weeks into nCRT at interim (IM), and after completion of
nCRT at first follow-up (FU). All scans were performed on a single GE 3.0 T MR750W
scanner using a 32-channel phased-array body coil. At the start of this study, two separate
DWI protocols were included in MR exams: a standard ssEPI diffusion scan for fitting with a
mono-exponential model, and an rFOV scan by FOCUS (2D RF excitation method on GE
platform) for fitting with an IVIM model. For the IVIM scan FOCUS protocol, the AP
direction was chosen as the reduced phase encoding dimension. This dimension was reduced
by half, resulting in a rectangular FOV. Later, in January 2016, another ssEPI scan with
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higher b-values was added to the study for diffusion kurtosis analyses. Henceforth, these
scans will be referred to by the diffusion model they were designed for: MONO, IVIM and
DKI, respectively. For MONO and DKI scans, acceleration by parallel imaging was utilized.
The typical acquisition parameters for these three scans are shown in Table 2-1.
Table 2-1. Typical scan parameters for DWI scans.
Protocol # of
Slices
MONO 50

TE
(ms)
69.7

TR
(ms)
5195

Thickness
(mm)
4.0

Matrix FOV
Approx. Scan
(cm)
Time (m:s)
96 x 96 46 x 46 4:41

IVIM

16

62.4

3000

4.0

96 x 96 24 x 12 5:38

DKI

40

52.7

4500

4.5

96 x 96 42 x 42 6:21

For each DWI scan, diffusion images were taken using a distinct selection of bvalues. For the MONO scan, b-values were selected based on the methodology of Padhani et
al. (26). This methodology requires the selection of three b-values. First, a b0 image is
acquired for reference to T2 images. Second, a mid-range b-value (between 200 and 500
s/mm2) is selected, which will aid ADC fitting by measuring signal loss at a lower b-value.
The exact value of this mid-range b-value is specific to the anatomic site being imaged, and
must be high enough to avoid variation in perfusion effects on signal loss. In the esophagus, a
b-value of 200 s/mm2 is sufficient for this purpose. Finally, a third high b-value must be
included. This is to further characterize signal loss from diffusion in the mid b-value region
where signal loss is dominated by diffusion. For the esophagus, a value of 800 s/mm2 was
chosen.
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For IVIM scans, several low and intermediate b-values were chosen to separately
characterize diffusion and perfusion effects. For DKI, several intermediate and high b-values
were chosen to separately characterize Gaussian diffusion and diffusion impacted by
kurtosis. Higher b-value diffusion images were acquired with multiple excitations (NEX,
number of excitations) and averaged. The benefit of NEX is increased SNR. SNR increased
with the square root of the number of NEX taken. B-values and their respective NEX for
each of the diffusion scans are presented in Table 2-2.
Table 2-2. B-values and NEX for diffusion scans.
Protocol

b-values (s/mm2) [NEX]

MONO

0 [2] , 200 [2], 800 [6]

IVIM

0 [2], 30 [2], 60 [2], 100 [4], 600 [16]

DKI

200 [2], 600 [4], 1000 [8], 1200 [12], 1600 [16]

For each scan, diffusion sensitization gradients were applied in three directions for
each non-zero b-value, and averaged to provide combined diffusion images. All diffusion
scan were acquired with free-breathing of the patient. Neither co-registration nor geometric
correction was applied to diffusion images. Although these corrections would provide benefit
by minimizing distortions and misalignment between diffusion images due to motion, there is
evidence that non-linear effects on signal level from these corrections leads to incorrect
estimation of diffusion parameters. An experiment performed in-house using standard
correction methods revealed a change of up to +/-5% in ADC values for MONO scans.
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2.3

Diffusion Parameter Mapping
Diffusion parameter map estimation was performed using an in-house software

named ImageI, which was designed and developed in our own lab. This software was
implemented in the Matlab application development environment (Mathworks, Natick, MA).
ImageI offers a convenient environment and a variety of useful features for the work
performed in this project. Its capabilities will be expounded in the relevant methods sections
of this thesis. For fitting of parameter maps, ImageI uses slightly differing methods of nonlinear least mean square (LMS) curve fitting for each model. Calculating ADC is
accomplished by finding the LMS solution for ADC on a voxel-by-voxel basis using all three
b-values. In ImageI (Matlab), this is implemented using the pinv function, as shown in the
pseudo-code of Equation 15.
Equation 19: Pseudo-code for Mono-exponential ADC Estimation

#Calculate signal ratios in log(S/S0) form

Diff_image = diffusion_images(b0,b200,b800)./diffusion_images(b0_meas)
Diff_image = log(Diff_image)

#Solve inverse squares problem to estimated ADC
pb = pinv(-200,-800);
For All Voxels
ADC = pb*Diff_image(b200,b800)
End
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In the case of fitting the MONO diffusion images with a mono-exponential model,
ImageI was validated against an industry standard available in the Functool application of the
AW workstation by GE (Boston, MA). For the specific case of measuring ADC mean across
volume contours of esophageal cancer, the GE and ImageI methods of producing ADC maps
have been shown to be equivalent. Further details on this comparison can be found in the
Appendix 5.1.
A second method of ADC calculation described by Padhani et al. was compared with
the ImageI and industry-validated methods (26). The Padhani et al method does not use b0
images for ADC estimation and instead directly calculates ADC from the solution of b200
and b800 signals. ADC estimation in ImageI was also another standard method of ADC
calculated by b0 and b800 is also included. The results of this comparison are shown in the
Appendix 5.6. A graph of the curve fitting of MONO signal levels for an individual voxel
can be seen in Figure 2-1.

Figure 2-1: Comparison of LMS fitted ADC plot with plotted measured signal values for
a single voxel.
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Industry standards for fitting IVIM and DKI models are not yet available from GE
AW Functool. Because of this, the ImageI methods for estimating these parameter maps has
not been validated against an industry standard. In the case of IVIM, a variety of parameter
fitting methods have been described in literature (64). The method used by ImageI is wellestablished (65). In this method, an initial guess for the true-diffusion coefficient, D, is
calculated from a direct solution of signal levels from two diffusion images. From this initial
ADC estimate, an estimation of S0 is then calculated. Then, the difference between the
estimated S0 and measured S0 is divided by the measured S0 to create an initial guess for the
perfusion fraction, f. These initial guesses were combined into the LMS algorithm for the
estimation of IVIM parameter maps. During LMS estimation, S0 signal levels were allowed
to iteratively change from the measured S0 signal. This flexibility allows for better fitting of
lower b-value signals with the IVIM model. Pseudo-code for this non-linear LMS
implementation is shown in Equation 20. A graph of the curve fitting of IVIM signal levels
for an individual voxel can be seen in Figure 2-2.
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Equation 20: Pseudo-code for IVIM Parameter Mapping

#Calculate signal ratios in log(S/S0) form

Diff_image = diffusion_images(b0,b30,b60,b100,b600)./diffusion_images(b0_meas)
Diff_image = log(Diff_image)

#Use LMS to solve for ADC
For All Voxels
parameter_holder=lsqcurvefit(@((1-f)exp(-b.*D)+(f)exp(-b.*D*)),initial_guess,Diff_image)
End
#Where parameter_holder is a 4D matrix containing 3D maps of perfusion fraction, pseudo-diffusion
coefficient, true-diffusion coefficient, and final b0 estimation.

Figure 2-2: Comparison of LMS fitted IVIM model with measured signal values for a
single voxel.
For DKI parameter fitting, initial estimates of ADC and S0 were also obtained using
b200 and b600 images. These estimates were used in a non-linear LMS estimation
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implementation similar to IVIM, as shown in Equation 21. A graph of the curve fitting of
DKI signal levels for an individual voxel can be seen in Figure 2-3.

Equation 21: Pseudo-code for DKI Parameter Mapping
#Calculate signal ratios in log(S/S0) form

Diff_image = diffusion_images(b200,b600,b1000,b1200,b1600)./diffusion_images(b0_est)
Diff_image = log(Diff_image)

#Use LMS to solve for ADC
For All Voxels
parameter_holder=fminsearch(@(sum(Diff_image,exp(-b.*ADC+b2.*ADC2.*k)),initial_guess,Diff_image)
End
#Where parameter_holder is a 4D matrix containing 3D maps of ADC and k.
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Figure 2-3: Comparison of LMS fitted DKI model with measured signal values for a
single voxel. A plot of the kurtosis model is seen in red, while a plot of the DKI-calculated
ADC as a mono-exponential decay is seen in green. Deviation of the signal from monoexponential behavior can be seen at high b-values.
Across all models, some numeric bounds were used to mask out non-physical values
for diffusion parameters. For the diffusion parameters ADC, D*, D, and k, negative values
were excluded. For the perfusion fraction f, negative values or values above 1.0 were
excluded. No other exclusion of diffusion parameters was made based on their quantitative
values.
ImageI offers fast, automated import of DICOM files followed by automatic
calculation of parameter maps. On a multi-core external server, estimation of parameter maps
of scans with parameters matching those in Table 2-1 took approximately 2 minutes for
MONO scans, 30-40 minutes for IVIM scans, and 1.5-2 hours for DKI scans. After
estimation of parameter maps, ImageI creates a single database file (.dat) which contains
diffusion images, parameter maps, patient information, and a reserved space for contour
masks.
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2.4

Contour Measurements of Diffusion Parameters
To measure diffusion parameter values within each tumor, contours delineating the

tumor from surrounding tissue were produced. Besides the technology used to make these
contours, a few strategies to ensure consistency and accuracy of contours were developed.

2.4.1 General Contour Strategies
Across the contouring methods used in this paper, a few general strategies were used.
First, all contours were performed on b200 images for MONO and DKI, and b100 for IVIM.
This was chosen out of the possible options of contouring on any of the diffusion images or
the ADC map. The decision to avoid contouring on b0 images was simple: although b0
images have the highest signal, they do not contain diffusion contrast needed to delineate
tumors. Higher b-value images and ADC maps were not chosen as contouring images
because although they are highly tumor specific, heterogeneity within the tumor may lead to
high variations in high b-value diffusion images and ADC maps. This heterogeneity could
cause readers to contour only certain sections of the tumor with more hindered diffusion. For
volume contouring, it is important to include all voxels of the tumor so as to completely
capture the diffusion behavior throughout. Another simple and more practical reason was
included in the decision to contour on lower b-value diffusion images: at later stages of
treatment, diffusion becomes less hindered. This reduces signal in the higher b-value
diffusion images, making contouring more difficult by manual and semi-automatic
contouring methods. By using a lower b-value, greater ease of contouring on IM and FU
scans was achieved.
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A second contouring strategy was introduced for the purpose of delineating the
superior and inferior (SI) extents of the tumor (proximal and distal by GI anatomy). For
contouring on diffusion images, the poor resolution in the slice dimension (4-4.5 mm in these
scans) makes location of the superior and inferior slices of the tumor difficult. This difficulty
is most severe at the inferior extent in tumors at the GE junction, where T2 shine-through of
cardium tissue is a large issue. To standardize contouring measurements in this dimension, a
method was created for finding this superior and inferior extent of the tumor. In the case of
using this method on MONO scans, the b200 map is first used to locate the tumor. Then,
approximate superior and inferior boundaries based on b200 images are found. After this, the
reader will switch to ADC maps on a nearby slice where tumor location is certain. The dark
area of the ADC map corresponding to the area of the tumor is then located. This dark region
of the ADC maps is traced through slices until it disappears. This disappearance is far more
distinct than SI changes in the b200 diffusion images, and marks the SI boundaries of the
tumor. These boundaries can then be propagated to b200 diffusion images for contouring.
Visualization of this phenomena on MONO exams is shown in Figure 2-4.
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Figure 2-4: This figure demonstrates the indistinct SI boundaries in the b200 images and
the distinct SI boundaries in ADC maps. It can be seen that the b200 images demonstrate
a noticeable, but indistinct lowering of signal as slices are they sequentially examined in
the inferior direction towards the inferior boundary of the tumor (upper row,
leftright). The ADC map (bottom row) demonstrates a distinct inferior boundary
when examined in this manner, which can be noticed as a large rise in ADC values
between the second and third image. Red arrows in the leftmost images mark areas of
low ADC corresponding to tumor, and the red arrow in the third image marks where
this area of low ADC is missing.
A third contouring strategy was added to account for cases in which tumor signal
dropout occurs on a single slice on the diffusion images of the b-value used for contouring.
This “flashing” artefact may occur because of large motion or single slice failure of parallel
imaging correction. Flashing artefacts are easy to notice by the readers. When encountered,
the entire slice can be excluded to prevent skewing the estimation of the tumor ADC. Images
of this artefact and others can be found in the Appendix 5.4. Other b-value images were not
searched for flashing artefacts so as to minimize time needed for contouring.
A fourth contouring strategy was developed to deal with misalignment of diffusion
images due to motion and distortion. The method is simple: readers would slightly under49

contour the edges of tumors. This prevents the inclusion of the incorrectly estimated ADC
values present at tumor borders misaligned between diffusion images.
The last notable contouring strategy used in this research was to exclude the lumen of
the esophagus. ImageI has a salient feature to allow “holes” in the images to be excluded
within contours. This exclusion allows further implementation of the under-contouring
method around the interior edges of the tumor. Morphologic distention within the esophagus
may also trap fluids within the lumen. Inclusion of voxels containing trapped liquid would
not be representative of the tumor and would artificially raise ADC summary measures
extracted from the contour. An example of lumen exclusion can be seen in the results section
(Figure 3-2).

2.4.2 Software Implementation
Contour measurements were performed across MONO scans of all surgical patients
using two distinct methods: volumetric contouring and slice contouring. Volumetric
contouring is only available through research tools. In the current clinical setting of
MDACC, only slice contouring is currently available through the PACS system.

2.4.2.1

Volumetric Contouring

Volumetric contouring was accomplished through the combined use of two software:
ITK-SNAP (www.itksnap.org.) (66) and ImageI. Although ImageI is initially used for
DICOM import and parameter map estimation, primary delineation of the tumor was
performed in ITK-SNAP.
ITK-SNAP is an open-source, semi-automatic contouring suite. It offers user-guided
semi-automatic contouring by the level-set algorithm, among several other algorithms (66).
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Contouring by the level-set algorithm is advantageous for diffusion images because the levelset algorithm is robust to high signal variation (66). This is especially important for
propagation of contour boundaries in the low-resolution slice direction of diffusion images.
Within ITK-SNAP, DICOM files of the diffusion images used for contouring (EX:
b200 for MONO) were imported. Contours were then produced using the Active Contour
Segmentation option. For pre-segmentation, the Thresholding method was used, with a
maximal selected upper threshold and a user-prescribed lower threshold. From here, several
3D “bubbles” were placed as seeds from which the initial iteration of the contour would
propagate. Bubbles were selectively placed to ensure propagation of contour throughout all
sections of the tumor. After this, contour evolution was executed and then terminated when
the tumor was encompassed. Usually, this resulted in a useable contour. A full guide with
screenshots visually detailing the steps of this method is shown in the Appendix 5.2. Once a
useable contour was derived using ITK-SNAP, a binary mask was exported in DICOM
format and then imported into ImageI.
Fine manual adjustments and finalizing of the contour were performed after the initial
delineation by using the toolbox available within ImageI. It provides paintbrush and eraser
tools, as well as polygon and freehand semi-automated contouring by the Snake algorithm.
ImageI also allows for histogram slider exclusion of signal values across tumor volume or
individual slices. With these tools, contours were finalized by erasing areas where the semiautomatic contour had propagated into adjacent tissues and by smoothing the edges of the
contours to fit the tumor boundaries.
After contouring was completed, extraction of diffusion parameters was executed
using ImageI. This included the following summary measures across volume extracts of
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diffusion parameters: max, min, mean, standard deviation, median, histogram kurtosis,
histogram skewness, 10th percentile, 25th percentile, 75th percentile, and 90th percentile.
ImageI also extracted the length of contoured SI extent and contoured tumor volume. It
should be noted that in this instance, histogram kurtosis examines the kurtosis of diffusion
parameter levels across a histogram of voxels in the contour. This should not be confused
with the kurtosis effect observed in high b-value diffusion imaging.
A separate extraction of all diffusion parameter summary measures was made for the
largest single slice within the contour. This was done with the intent of acting as a proxy for
single slice contouring. Comparison of largest slice metrics with actual single slice
contouring can be found in the Appendix 5.7.
All extracted measures were combined and exported into an Excel file using a single
button click within ImageI. A full workflow map of all steps between acquisition and
extraction by volume contour can be found in Figure 2-5.
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Figure 2-5: Workflow for measurement of diffusion parameters through volume
contouring.
It is important to note that contouring performed by the initial reader (the author of
this thesis) was not performed using ITK-SNAP. The previously described contouring
method was only used by the readers in the inter-reader study. Contouring by the initial
reader (R1) was performed manually using the contouring toolbox within ImageI. Further
details on the strategies of their implementation is presented in the Appendix 5.3.
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2.4.2.2

Slice Contouring

The implementation of slice contouring is more simplistic than that of volume
contouring. First, ADC maps generated by GE Functool using diffusion images were
exported to PACS. Then, using localizer mode within Phillips Intellispace, freehand contours
were drawn onto the ADC map while tracing the b200 image. From here, ADC mean and
standard deviation of the contour were recorded. This measurement was only performed on a
single slice. Slice selection was left to each reader, whose only guidance in this selection was
to select a slice which was at the midline of the tumor and judged to have the largest cross
section. With this slice contouring method, readers were unable to exclude the esophageal
lumen.
Within Phillip Intellispace, freehand contours were saved as presentation states and
then reviewed later to insure correct recording of ADC mean and standard deviation. A full
workflow map for estimation and measurement of diffusion parameters by slice contouring
can be found in Figure 2-6.
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Figure 2-6: Workflow for measurement of diffusion parameters through slice contouring.

2.5

Inter-Reader Study
For the inter-reader study, four additional readers contoured MONO scans using both

volumetric and slice contouring techniques. These readers included an experienced thoracic
radiation oncologist, an experienced thoracic radiologist, and two radiation oncology
residents. Before contouring, readers were given training across several datasets. They were
then assigned randomized orders in which to contour all surgical MONO exams. They
completed contours of these exams as volumetric contours using previously described
volume contour methods and with slice contouring using the clinically available method.
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Throughout contouring, all readers were blinded to the contours of other readers as well as
the histopathological groupings of the patients.

2.6

Statistical Analysis
Statistical analysis was performed in Matlab, an open-source statistics software

named R (GNU), and Prism by GraphPad Software (San Diego, California). P-values less
than 0.05 were considered statistically significant.

2.6.1 Correlation of Diffusion Parameter Summary Measures with
Histopathology
Diffusion parameters summary measures were compared for heterogeneity between
tumor histologic groupings. Two major comparisons were made. The first compared
diffusion parameter summary measures between TRG1, TRG2 and combined TRG3+ using
one-way three-factor ANOVA or the Kruskal-Wallis (KW) test. A second method compared
diffusion parameter summary measures between a binary grouping of patients as pCR
(TRG1) and non-pCR (combined TRG2 and TRG3+) using a non-parametric t-test or MannWhitney (MW) u-test. The second comparison between binary groupings was extended to
receiver operator curve (ROC) analysis. Optimal cutoff for classifying patients into the
binary grouping were calculated using Youdens’s index. To test for the possibility of
building a multi-parametric model, Spearman’s rank was used to assess correlation between
diffusion parameter summary measures.
A third, less important comparison was also applied, where the binary definition was
altered so that patients with <1% viable cell histopathology were compared with pCR
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patients and a grouping of >=1% viable cells patients. This comparison is not relevant to a
clinical endpoint. Instead, this comparison was performed to examine the sensitivity of
quantitative diffusion parameters to differences between histopathologic groups which are
seemingly close (0% viable cells vs <1% viable cells). Results of this comparison can be
found in the Appendix 5.5.

2.6.2 Inter-Reader Reproducibility Analysis
Inter-reader reproducibility was evaluated through three methods. First, quantitative
measures were compared for reproducibility between readers using Bland-Altman analysis.
Bland-Altman analysis results in a metric known as the 95% Limits of Agreement (LOA),
which shows the likely distance between measurements of a system by separate readers.
Second, contouring measures of individual readers were examined for performance under ROC
analysis using the binary patient grouping. Both of these methods were applied to results
obtained through both volume and slice contouring.
Finally, comparison of spatially contoured volumes was compared between readers
using the Dice Similarity Coefficient (DSC). This was performed using Equation 22.

Equation 22: 𝑫𝑺𝑪 =

# 𝒐𝒇 𝑺𝒉𝒂𝒓𝒆𝒅 𝑽𝒐𝒙𝒆𝒍𝒔
(# 𝑽𝒐𝒙𝒆𝒍𝒔 𝒊𝒏 𝑪𝒐𝒏𝒕𝒐𝒖𝒓 𝑨)+(# 𝑽𝒐𝒙𝒆𝒍𝒔 𝒊𝒏 𝑪𝒐𝒏𝒕𝒐𝒖𝒓 𝑩)

Averages of DSC’s across patients and between all pairings of readers were found for
BL, IM and FU separately. Average DSC for each individual reader across all pairings to other
readers, all patients, and all time-points were also calculated.
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3

Results

3.1

Patient Enrollment
In total, 59 patients have been enrolled in the study. Several patient enrolled in the

study did not undergo surgery because their disease had already metastasized, they had poor
cardiopulmonary health, or they refused surgery (n = 39). These patients are not included in
this analysis because currently elapsed follow-up time is inadequate for outcome analysis
based on survival measures. The remaining 20 surgical patients are included within this
analysis. According to the histopathological analyses of these twenty surgical patients, five
exhibit pCR to nCRT (TRG1/pCR: n = 5), nine exhibit partial response to nCRT (TRG2: n =
9) and six patients exhibit limited response to nCRT (TRG3: n = 6). A more complete
presentation of patient characteristics can be found in Table 3-1.
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Table 3-1. Patient and Pathology Characteristics
Characteristic
Gender
Male
Female
Age (years)
Histological Tumor Type
Adenocarcinoma
Squamous cell carcinoma
Histological Tumor grade
Well Differentiated
Moderately Differentiated
Poorly Differentiated
Clinical Stage
IIa
IIb
IIIa
IIIb
Tumor Location
Proximal third
Middle third
Distal third
Gastro-esophageal junction

N (%)
20 (100.0)
0 (0.0)
62.1+/-8.0*
17 (85.0)
3 (15.0)
0 (0.0)
9 (55.0)
11 (45.0)
1 (5.0)
5 (25.0)
12 (60.0)
2 (10.0)
0 (0.0)
1 (5.0)
17 (85.0)
2 (10.0)

Histopathologic T-stage
ypT0
5 (25.0)
ypT1a
2 (10.0)
ypT1b
2 (10.0)
ypT2
3 (15.0)
ypT3
8 (40.0)
Histopathologic N-stage
ypN0
14 (71.4)
ypN1
4 (20.0)
ypN2
2 (10.0)
ypN3
0 (0.0)
Histopathologic Tumor Regression Grade
TRG 1
5 (25.0)
TRG 2
9 (19.0)
TRG 3-5
6 (30.0)
*Patient age is listed as mean+/-std
It should be noted that Table 3-1 describes the patient characteristics of all patients
who underwent surgery and had useful MONO exams at BL and IM. For IVIM, one patient
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(TRG1) is excluded because of a failed baseline exam (n=19 for BL and IM). Four patients
did not receive FU exams because of loss to follow-up (Remaining MONO at FU: n=16;
TRG1 = 4, TRG2 = 6, TRG3 = 6). In addition to this, IVIM scans were mistakenly not
acquired at FU for three additional patients (remaining IVIM at FU: n=13; TRG1 = 3, TRG2
= 5, TRG3 = 5).

3.2

Image Quality
With the exception of a baseline IVIM exam with failed acquisition (n=1), all other

acquired diffusion exams were of sufficient quality for quantitative volume measurements.
Examples of images by exam type can be found in Figure 3-1, Figure 3-2, and Figure 3-3 for
MONO, IVIM, and DKI, respectively.
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Figure 3-1: Diffusion images (a, b) and ADC map (c) from MONO exam of a patient at
BL. Contours made on b100 are overlain on the image in white. FDG-PET (d), T2weighted image (e), and CT (f) images of the approximate slice are included for
comparison.
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Figure 3-2: Diffusion images (a, b) and parameter maps (d-e) from IVIM exam of a
patient at BL. Contours made on b100 are overlain on the image in red. A T2-weighted
image (c) of the approximate slice is included for comparison.
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Figure 3-3: Diffusion images (a-c) and parameter maps (d,e) from DKI exam of a patient
at BL. Contours made on b200 are overlain on the image in white. A T 2-weighted image
(f) of the approximate slice is included for comparison.
Several artefacts were seen in the images: “flashing” artefacts (parallel imaging
failure or large motion on a single slice), slight misalignment due to motion, and T2 shinethrough artefacts. Flashing artefacts were excluded through avoidance of single slices during
contouring, and occurred infrequently (around 1 to 2 flashing artefacts for every 5 scans). T2
shine-through resulted in subjectivity in contouring the inferior edge of tumor at the
gastroesophageal junction. Images and further details of these artefacts can be found in the
Appendix 5.4.
Two major errors in scan acquisition occurred while obtaining scans of surgical
patients. The first was the failed baseline IVIM scan due to failed calibration. The second
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major error was a calibration failure during the first five slices of a MONO scan. Because the
tumor was not near the location of these slices, the scan was considered useable and included
in this analysis.

3.3

Correlation of DWI Parameters with Histopathology
Unfortunately, DKI data cannot be reported upon presently because of insufficient

patient accumulation (n = 25 patients, only 2 with surgery). The results of correlation of
diffusion parameter summary measures of MONO (n=20) and IVIM (n=19) with
histopathology are presented here for the volume contouring of the initial reader.

3.3.1 Mono-exponential Model (ADC)
Across ADC summary measures at all time-points and as relative changes between
time-points, any differences between 3-factor TRG groupings detected with KW test were
simply the extension of differences displayed with the binary grouping method (pCR vs nonpCR). No difference was found between the ADC summary measures in TRG2 and TRG3+.
Because of this, KW test results are not reported here in favor of the binary comparison by
MW test.
At baseline, four summary measures of ADC were found to be significantly different
(p<0.05) by MW test between pCR and non-pCR. ADC mean and ADC median tied for the
most significant, with MW p-values of 0.0261 and AUC’s of 0.840. Statistical analysis and
values of these summary measures can be found in Table 3-2.
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Table 3-2. Comparison of Baseline ADC Summary Measure Distributions between pCR
and non-pCR using Mann-Whitney Test.
ADC Summary Measure

ADC Mean

ADC Median

ADC 75th Percentile

ADC 25th Percentile

p-value

0.0261

0.0261

0.0403

0.0493

TRG

ADC in x10-3 mm2/s

TRG1

2.22 +/- 0.17

TRG2

2.68 +/- 0.38

TRG3

2.48 +/- 0.28

TRG1

2.18 +/- 0.16

TRG2

2.66 +/- 0.41

TRG3

2.45 +/- 0.30

TRG1

2.57 +/- 0.21

TRG2

3.08 +/- 0.40

TRG3

2.86 +/- 0.33

TRG1

1.82 +/- 0.15

TRG2

2.27 +/- 0.40

TRG3

2.10 +/- 0.28

AUC

0.840

0.840

0.813

0.800

Baseline values of volume ADC mean were not significantly different between ESCC
patients (n=2) and AEC patients (n = 18) using MW u-test (p>0.08). MW test did not
demonstrate any difference in distribution of ADC summary measures between pCR and nonpCR patients at IM or FU.
Relative change in ADC (ΔADC) summary measure at IM produced excellent
separation between binary grouping of patients as pCR and non-pCR. Several ADC summary
measures resulting in AUC=1 by ROC analysis. The top five ΔADC summary measures by
MW p-value are listed in Table 3-3.
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Table 3-3. Comparison of Distributions of ΔADC Summary Measures between pCR
and non-pCR using Mann-Whitney Test.
Summary Measure p-value
ADC Mean

TRG

Relative % Change (Mean +/- STD) AUC

0.001063 TRG1 37.73 +/- 8.77

1.000

TRG2 9.17 +/- 9.43
TRG3 9.77 +/- 4.01
ADC 25th Percentile 0.001063 TRG1 47.12 +/- 11.18

1.000

TRG2 9.55 +/- 10.51
TRG3 11.60 +/- 4.40
ADC 10th Percentile 0.001063 TRG1 53.23 +/- 20.46

1.000

TRG2 8.60 +/- 15.26
TRG3 12.51 +/- 7.31
ADC Median

0.001443 TRG1 39.63 +/- 9.20

0.987

TRG2 10.59 +/- 9.38
TRG3 10.74 +/- 3.65
ADC 75th Percentile 0.001944 TRG1 35.73 +/- 12.11

0.973

TRG2 10.37 +/- 10.08
TRG3 8.07 +/- 4.98

Youden’s index was used to calculate an optimized cutoff for the top performing
parameter, ΔADC mean. This value was found to be a 27.7% change in ADC mean. A dot plot
comparing ΔADC mean between pCR and non-pCR can be found in Figure 3-4.
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Figure 3-4: Comparison of distributions in ΔADC mean between pCR and non-pCR
groupings. P-value by MW test is shown at top. The 27.7% cutoff between pCR and
non-pCR is shown as a dotted line. 95% confidence intervals and means are displayed
with crosshairs for each group.
By Spearman’s rank, the top ΔADC summary measures at interim were found to be
highly correlated. This result is depicted for the top 10 performing ΔADC summary measures
in Figure 3-5.
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Figure 3-5: Spearman’s correlation matrix of the top 10 performing summary measures
of ΔADC.
No difference in distributions of ΔADC summary measures at FU was found between
pCR and non-pCR. Change in contoured tumor volume between BL and IM or FU were not
significantly different between binary response groups.

3.3.2 IVIM Model
As with MONO, any differences between 3-factor TRG groupings detected with KW
test were simply the extension of differences present in the binary grouping method (pCR vs
non-pCR). Because of this, only differences based on the binary grouping are presented in this
section.
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Many baseline summary measures of IVIM parameters were highly different between
pCR and non-pCR groupings. The IVIM parameter summary measure with the highest MW
p-value at BL was D min, with an AUC = 0.950 by ROC. The top 5 performers by MW test pvalue are shown in Table 3-4.

Table 3-4. Comparison of Baseline IVIM Parameter Summary Measures
between pCR and non-pCR using MW test.
Summary Measure

p-value

TRG

D/D* (x10-3 mm2/s)

TRG1

0.0613 +/- 0.1226

TRG2

0.5045 +/- 0.2207

TRG3

0.3534 +/- 0.2422

TRG1

12.05 +/- 2.87

TRG2

18.79 +/- 6.43

TRG3

18.44 +/- 2.80

TRG1

1.04 +/- 0.53

TRG2

2.08 +/- 0.59

TRG3

1.74 +/- 0.40

TRG1

0.80 +/- 0.49

TRG2

1.70 +/- 0.53

TRG3

1.40 +/- 0.35

TRG1

1.02 +/- 0.53

TRG2

2.03 +/- 0.58

TRG3

1.70 +/- 0.38

AUC

D
0.00693

0.950

Min

D*
0.00932

0.933

Mean

D
0.0124

0.917

Mean

D
0.0124

0.917

th

25 Percentile

D
0.0124

0.916

Median
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When IVIM parameters summary measures were compared between pCR and nonpCR as relative changes at IM, 10 were found to be significantly different between groups. Of
these, only two were not summary measures of the true-diffusion coefficient (D): pseudodiffusion D* 90th percentile and perfusion fraction f 90th percentile. A list of these summary
measures, their MW p-values, and their AUC’s can be found in Table 3-5.
Table 3-5. Comparison of Distributions of ΔIVIM Summary Measures at IM between
pCR and non-pCR using Mann-Whitney Test.
Summary Measure p-value TRG
D
90th Percentile

Relative % Change (Mean +/- STD) AUC

0.00270 TRG1 40.35 +/- 17.89

1.000

TRG2 9.75 +/- 12.75
TRG3 4.31 +/- 5.90

D
mean

0.00270 TRG1 43.48 +/- 16.69

1.000

TRG2 9.50 +/- 11.76
TRG3 6.99 +/- 10.18

D
Max

0.00270 TRG1 33.75 +/- 13.91

1.000

TRG2 1.29+/- 7.93
TRG3 0.51 +/- 9.45

D
25th Percentile

0.00270 TRG1 47.58 +/- 21.80

1.000

TRG2 8.77 +/- 10.88
TRG3 8.17 +/- 14.61

D
75th Percentile

0.00373 TRG1 42.70 +/- 17.78

0.983

TRG2 10.38 +/- 13.05
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TRG3 6.43 +/- 8.55
D

0.00373 TRG1 44.81 +/- 16.01

Median

0.983

TRG2 10.26 +/- 12.23
TRG3 8.44 +/- 11.23

D*

0.00767 TRG1 662.26 +/- 650.29

Min

0.933

TRG2 62.98 +/- 212.26
TRG3 0.73 +/- 55.03

D

0.01242 TRG1 39.81 +/- 25.64

Standard Deviation

0.917

TRG2 9.90 +/- 13.65
TRG3 0.24 +/- 7.63

f

0.02781 TRG1 31.68 +/- 18.63

90th Percentile

0.867

TRG2 10.63 +/- 11.15
TRG3 8.29 +/- 12.31

D

0.02781 TRG1 53.57 +/- 43.60

10th Percentile

0.867

TRG2 7.25 +/- 12.27
TRG3 9.28 +/- 15.24

Youden’s index was used to calculate an optimized cutoff for the top performing
parameter, ΔD 90th percentile. This optimized cutoff was also found to be a 27.7% change in
D 90th percentile. A dot plot comparing ΔD 90th percentile between pCR and non-pCR can be
found in Figure 3-6.
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Figure 3-6: Comparison of distributions in ΔD 90th Percentile between pCR and non-pCR
groupings. P-value by MW test is shown at top. The 27.7% cutoff between pCR and nonpCR is shown as a dotted line. 95% confidence intervals and means are displayed with
crosshairs for each group.
By Spearman’s rank, the top 10 ΔIVIM summary measures at interim were found to be
highly correlated. This result is depicted in Figure 3-7.
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Figure 3-7: Spearman’s correlation matrix of the top 10 performing summary measures
of IVIM diffusion parameters as relative change at IM.
For IVIM, several significant differences in distributions of ΔD and ΔD* summary
measures as relative changes at FU were found between pCR and non-pCR. These results are
not clinically useful because they do not predict response at an early time-point. All of these
measures are listed in Table 3-6.
Table 3-6. Comparison of Distributions of ΔIVIM Summary Measures at FU
between pCR and non-pCR using Mann-Whitney Test.
Summary Measure p-value TRG Relative % Change (Mean +/- STD)
D*
0.0102 TRG1 66.42 +/- 35.51
Standard Deviation
TRG2 11.06 +/- 17.42
TRG3 -61.92 +/- 52.36
D
0.0158 TRG1 7.53E10 +/- 1.30E11
min
TRG2 30.28 +/- 100.21
TRG3 -57.00 +/- 58.90
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D
Max

0.0240

D*
90th Percentile

0.0240

D*
Mean

0.0356

D*
75th Percentile

0.0356

TRG1
TRG2
TRG3
TRG1
TRG2
TRG3
TRG1
TRG2
TRG3
TRG1
TRG2
TRG3

52.42 +/- 46.42
-9.15 +/- 18.89
-56.60 +/- 60.41
111.49 +/- 60.33
17.13 +/- 34.78
-63.18 +/- 50.82
110.36 +/- 106.42
22.80 +/- 45.18
-63.29 +/- 50.56
163.58 +/- 193.84
33.39 +/- 63.21
-62.21 +/- 52.78

It is interesting to note that D summary measures were better classifiers of the binary
grouping as relative changes at IM, while D* summary measures were better classifiers of
the binary grouping as relative changes at FU. Change in contoured tumor volume between
BL and IM or FU were not significantly different between binary response groups.
Because D from IVIM and ADC from MONO are both estimations of the diffusion
coefficient, it was thought that a comparison of these estimations may be interesting. This
comparison can be found in the Appendix 5.8.

3.4

Inter-Reader Study
Results of the inter-reader study as 95% LOA and AUC analysis can be found for top

5 performing ADC summary measures by volume contouring and all slice contouring ADC
measures in Table 3-7. Bland-Altman plots are presented for the top performing summary
measures of ADC as decided by maximum AUCmin (ΔADC 25th Percentile and mean) in Figure
3-8.
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Table 3-7: Inter-Reader Reproducibility for MONO ΔADC Summary Measures by
Bland-Altman and ROC Analyses.

ΔADC

95% LOA

Summary Measure

(per sd)

R1

R2

R3

R4

R5

Volume 10th Percentile

0.940

1.000

1.000

0.987

1.000

0.960

Volume 25th Percentile

0.944

1.000

1.000

0.987

1.000

1.000

Volume Mean

1.001

1.000

1.000

0.973

0.973

1.000

Volume 75th Percentile

1.010

0.973

1.000

0.947

0.880

0.933

Volume Median

1.021

0.987

1.000

0.933

0.960

1.000

Slice ADC Mean

1.517

0.893

0.800

0.880

0.773

0.880

Slice ADC STD DEV

1.738

0.507

0.533

0.613

0.600

0.600

AUC
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Figure 3-8: Bland-Altman plots comparing inter-reader variability for ADC 25th
percentile (a) and ADC mean (b) from MONO scans.
Comparison of contoured volumes across all patients and all possible reader pairings
produced average DSC’s of 0.73, 0.66, and 0.56 for BL, IM, and FU, respectively. The
maximum average DSC for all possible pairings of a single reader across all patients and
time-points was 0.69. The minimum average DSC for all possible pairings of a single reader
across all patients and time-points was 0.61.

4

Discussion

4.1

Response Prediction by DWI
The results of this study have shown diffusion parameters to be highly useful for

classification of surgical patients as pCR or non-pCR. Although the measured diffusion
parameters at baseline were significantly different between groups, the relative changes at
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interim in these diffusion parameters provided substantially better classifications of the
different patient TRG groups. Summary measures of ADC by MONO scans and D by IVIM
scans were able to perfectly classify patients by the binary response grouping. The minimum
value of D by IVIM scan at BL was an excellent classifier of the binary response grouping, but
is based on the measurement in a single voxel, making it unstable.
Results for the MONO exam closely parallel those from a previous study by Van
Rossum et al (29). Van Rossum’s study was organized nearly identically to this one in terms
of size, scan protocol, and patient histology. They found that an optimized cutoff of 29%
relative change in ΔADC median at interim best separated their pCR and non-pCR patients.
This is strikingly similar to the 27.7% result found in this study. Agreement between these two
papers was achieved in spite of geographically separated patient populations (North America
vs Western Europe) and different magnet strengths/manufacturers (GE 3.0 T vs Phillips 1.5
T). This study serves as a good validation of their results.
Thus far, only a single paper has been published on the use of IVIM in esophageal
cancer (67). This paper is not comparable to the data in this thesis because it does not concern
response to therapy and was performed with a patient population dominated by ESCC.

4.2

Reproducibility of Contour Measurements between Readers
Inter-reader reproducibility by Bland-Altman and ROC analysis showed excellent

reproducibility for measurements of several ΔADC parameter summary measures. The top
performing summary measure of ΔADC was the 25th percentile because it had the highest
minimum AUC between all readers (0.987). Slice contouring showed poor reproducibility
with a high 95% limit of agreement (1.517) and low AUC across all readers. It is evident that
slice contour is insufficient for measuring ADC for the prediction of response.
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It is interesting that the lower percentile measures of ΔADC (10th and 25th percentile),
show better LOA and AUC in comparison to other percentile measures (Table 3-7). This may
have two plausible explanations. The first is that lower values of ADC correspond to higher
signal on the diffusion images. Because high signal is the primary marker of tumor voxels in
diffusion images, it is more likely that areas of low ADC will be contoured by different
readers. A second explanation is the direct interpretation: change in diffusion behavior in the
most hindered voxels of the tumor is more representative of response to nCRT. This has been
shown previously for prediction of response to CRT in other anatomic sites (68-70). It is
likely that the reason for this result is a combination of these two factors.
DSC analysis for spatial agreement of contours may be interpreted using the
following ranges: values are considered by where they fall in the following ranges: 0.00–0.20
poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good and 0.81–1.00 excellent agreement
(71). At BL and IM, average DSC fell into the “good” range, meaning that reproducibility of
spatial volume contours was good between readers. Average DSC for individual readers
across all patients and time-points was always above 0.61, meaning that all readers within
this study were able to perform contouring with spatial location that was in good agreement
with their peers. Results similar to this have been obtained by another group for contouring
on diffusion images of rectal cancer (72, 73).
Because of the excellent performance of MONO scans with respect to classifying
pCR and reproducibility of contour measurements, we have not examined the inter-reader
reproducibility for IVIM scans.
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4.3

Limitations
A major limitation of this work is the small dataset of surgical patients (n = 20). It is

unlikely that the perfect separation of pCR and non-pCR patients will continue in a larger
dataset. This is evident in the small difference between the 27.7% cutoff and the highest %
ΔADCmean from the non-pCR group (27.04%), as well as the difference between the 27.7%
cutoff and the lowest ΔADCmean from the pCR group (28.39%).
Another limitation is the use of histopathological response as a proxy for survival
measures. Although histopathologic measures are highly predictive of survival, direct
knowledge of survival is far more powerful for the purpose of retrospective classification.
A third limitation is the location of the tumors in this study. Most of the tumors were
located in the distal third of the esophagus (n = 17, 85%). Only a few of the tumors were
located in the GE junction (n=2, 10%). The patient population of this study is not
representative of the general population, where incidence in the GE junction is more likely.
Accurate contouring is more difficult at the GE junction due to the T2 shine-through artefact
of the stomach. Because of this, diffusion parameter measurement in the general population
may be less reliable, which may impact the predictive value of DWI for response to nCRT.

4.4

Future Work
First, these results must be validated in a larger dataset. This will be accomplished

through the continued accrual of surgical patients, combination of these results with those
reported by Van Rossum et al., and through eventual KM analysis of non-surgical patients.
Surgical patients should also undergo KM analysis, as histopathology measures do not hold
the same value as survival measures.
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After this biomarker has been validated in a larger dataset, it must be tested
prospectively in a randomized Phase I clinical trial. In the experimental group of this trial, a
patient whose intra-tumoral volume ADC increases sufficiently to predict pCR from
chemoradiation alone will be withheld from surgery and placed under a wait-and-see
approach. Other patients in this experimental group whose change in volume ADC predicts
partial response will be sent for surgery (if able). In the control group, all patients will
undergo surgery if able, regardless of change in volume ADC. By comparing survival of
these two groups, it can be fully established if using DWI to predict response and avoid
surgery in pCR patients holds a clinical benefit.
For routine clinical use, a consistent and fast method of volume contouring of
diffusion images must be made available. The volume methods in this paper are fairly time
consuming, requiring approximately 5 minutes of time for an experienced reader to complete
a contour. In clinical workflow, this is much longer than a radiologist would typically spend
reading an image dataset. Thus, it would be advantageous if a robust, fully-automatic method
was clinically available for contouring. Recently, a paper has been published which uses
convolutional neural networks to contour stroke lesions on DWI of the brain (74). This and
other methods of automatic contouring may be investigated for their capabilities towards
contouring of diffusion images with reduced reader intervention and oversight.
It is possible that the lack of success of FDG-PET as a predictor of response is caused
by the non-specific uptake of FDG at IM such as from radiation induced inflammation. Nonspecific uptake makes delineation of the tumor on FDG-PET/CT images difficult, and
changes the values of summary measures such as standardized uptake value (SUV). It is
possible that combined DWI with FDG-PET would provide better localization for tumor-
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specific measurement of FDG-PET summary measures at interim. Co-registration of these
images would be improved if they could be acquired in a conserved frame of reference
within a PET/MR system. If FDG-PET measures were also found to be useful for prediction
of response, both FDG-PET summary measures and ADC summary measures could be
measured using a single set of contours acquired in an efficient, single machine setting. This
would be time-saving, and may improve delineation of the tumor for both modalities in
comparison to contemporaneous and separate acquisitions.
Once enough DKI patients have been accumulated, DKI will be investigated for
potential value in prediction of treatment response in esophageal cancer. The kurtosis
parameter has been shown as a useful biomarker of cancer in several anatomic sites (75-77).
It may hold useful information distinct from ADC that can be used towards predicting the
response of esophageal cancer to nCRT.
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5

Appendix

5.1

Validation of ADC Map Calculation by Comparison to GE Functool
For validation of ADC calculation by ImageI, ADC maps were generated using GE

Functool within a GE AW workstation and imported into ImageI. ADC extraction was
performed using each map on volume contours of five esophageal scans. These scans
including separate patients, variability in tumor size, and at least one scan from each timepoint (BL, IM, and FU). Extracted volume ADC mean were compared between the two ADC
mapping systems using an unpaired, two-sided Student’s t-test. Results of this comparison
are shown below in Table 5-1. Student’s t-test did not reveal any significant difference in
extracted volume ADC mean between the two methods (all p>0.46).
Table 5-1. Comparison between extracted volume ADC mean from ADC maps
generated by ImageI and GE Functool

Scan #
Scan 1
Scan 2
Scan 3
Scan 4
Scan 5

5.2

Volume
(cm3)
19.05
5.49
25.61
10.29
43.90

ImageI Mean ADC
(x10-3 mm2/s)
1.667 +/- 0.305
1.792 +/- 0.358
2.086 +/- 0.414
2.074 +/- 0.506
2.038 +/- 0.422

GE Mean ADC
(x10-3 mm2/s)
1.667 +/- 0.305
1.795 +/- 0.353
2.086 +/- 0.414
2.079 +/- 0.613
2.031 +/- 0.399

% Difference
-0.01%
-0.17%
0.00%
-0.25%
0.31%

Student’s p-value
0.99
0.90
1.00
0.83
0.46

ITK-SNAP Settings and Guide
This section is intended to act as a demonstration of our contouring technique in ITK-

SNAP. After diffusion images are imported into ITK-SNAP for contouring, the image must be
prepared for semi-automated contouring through a series of pre-segmentation steps. In this
example, the ITK-SNAP technique is applied to b200 images from a MONO scan. First, the
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reader should adjust the contrast by selecting Tools>Image Contrast>Contrast Adjustment.
This should be adjusted to the reader’s preferences. Then, the reader must select the Active
Contour Segmentation button, which is located on the upper left of the screen.
This will bring up a screen where the reader is asked to shrink the volume of the image
set to a small box which barely encompasses the tumor. This is done by dragged dashed red
lines to the edges of the tumor. The reader must be careful to include the entirety of all the
tumors dimensions by searching the axial, sagittal, and coronal views of the display. An
example of this volume minimization can be seen in Figure 5-1.

Figure 5-1: Minimization of volume for semi-automated contouring. The new smaller
volume is outlined in red lines. The display includes axial (Upper Left), sagittal (Upper
Right) and coronal (Bottom Right) views.
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Once the contouring volume has been shrunk, the user must select the Segment 3D
button in the left toolbar. The displayed images will change to include only the minimized
volume. The user must click on one of the small blue and white images displayed next to each
of the anatomic views. This will change all of the displays into blue and white “speed images”,
where a prediction of the semi-automatic contouring is displayed. White pixels represent pixels
which are predicted to be in the contour and blue pixels represent pixels which are predicted
to be excluded from the contour. For the protocol used in this paper, the Thresholding method
should be selected in the pull-down tab on the right toolbar. The user should then select the
More… button on the right toolbar to bring up a window showing application of threshold
limits to an image intensity histogram. The user should adjust the upper threshold to its
maximum limit. The lower threshold should be adjusted so that the predicted speed images
include the entirety of the tumor while minimizing predicted contouring of outside tissue. After
this step is complete, advancement to the next step can be accomplished by clicking the Next
button on the right toolbar. An example of this completed step can be seen in Figure 5-2.
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Figure 5-2: Final adjustments of thresholding for speed images of a minimized scan
volume. The display includes axial (Upper Left), sagittal (Upper Right) and coronal
(Bottom Right) views.
The last pre-contouring step is the placement of bubbles seeds, from which the contour
will propagate. For efficiency, a minimum number of bubble seeds should be placed. The
bubble size should be increased to maximize their dimension while still containing most of
their volume within the tumor boundaries. Multiple bubbles should be placed if the sections of
the tumor are disconnected, especially in the low resolution slice dimension. To place a bubble,
the reticle should first be placed in the middle of the tumor with a mouse click. Then the Add
Bubble at Cursor button on the right toolbar should be clicked. The radius of the placed bubble
can then be adjusted using the slider on the right toolbar. Incorrectly placed bubbles should be
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deleted by selecting them in the list on the right toolbar and clicking the Delete Active Bubble
button. Once bubble seeds have been placed, the Next button on the right toolbar should be
clicked for advancement of the contouring step. An example of good bubble placement can be
seen in Figure 5-3.

Figure 5-3: An example of good bubble seed placement within the tumor volume.
Next, the active contour must be activated. This can be done by clicking the “play
button” on the right toolbar. Once the contour has propagated to the preferences of the reader,
the “pause button” (which takes the place of the play button while active contours are being
iteratively updated) should be clicked to stop the contour. If the contour is acceptable, it can
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then be save and exported as binary masks in DICOM format. Screenshots of before and after
active contouring can be seen in Figure 5-4 and Figure 5-5.

Figure 5-4: Screenshot of active contouring step before active contouring is activated.
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Figure 5-5: Screenshot of completed contour after iterative update of contour boundaries
during active contouring has been stopped with appropriate timing.
If the contour fails to propagate throughout the entire tumor during the execution step,
Active Contour Segmentation may be repeated with additional bubbles or a lower signal
threshold. If the contour propagates too far, but still encompasses the entire tumor, the contour
can instead be corrected later.
ITK-SNAP is an open-source software offering free downloads and tutorials. It is
applicable to a wide range of biological imaging modalities. Excellent documentation, guides,
and more can be found at <www.itksnap.org>.
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5.3

Alternative Manual ImageI Contouring Method
This technique is fairly simple to implement, but requires significant manual input.

Despite this, good manual contours can be achieved with this method in under 5 minutes per
scan. This is comparable to the semi-automated method for BL scans. For IM and FU
scans where diffusion is less restricted and signal is lower on diffusion images, this method
may be faster than the semi-automated method. It can be accomplished in a series of three
steps.
First, the reader must completely contour the tumor on all slices. This contour should
be done roughly, the only goal being to completely encompass the tumor without including a
significant amount of adjacent structures (cardium, aorta, etc). In ImageI, this is done with the
paintbrush tool. An example of this rough outlining on a single slice can be found in Figure
5-6.
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Figure 5-6: Rough outlining of tumor using several sweeps of the paintbrush tool. This
should take on the order of a few seconds for each slice.
In the second step of this method, the rough contour will be drawn into the tumor edges
by excluding lower signal values. This can be done across using the volume histogram slider
in ImageI. Changes in the edges of the tumor should be tracked on a representative slice of the
tumor. The readers should slowly raise the minimum included signal value bar until the edges
of the tumor (including lumen) are contoured well. If the lumen is visible on any slices of the
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scan, one of these slices should be chosen for observation during histogram signal exclusion.
An example of this signal exclusion technique is shown for a single slice in Figure 5-7.

Figure 5-7: Example of edge contouring and lumen exclusion through raising minimum
included signal level using the volume histogram tool in ImageI. A red arrow shows the
movement of the slider, which was manually dragged by the user.
After the second step is applied, the contour should be nearly perfect. To complete the
contour, the reader must examine every slice and manually extend or contract edges of the
contour. The reader should also fill in any missing holes within the tumor contour that do not
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correspond to lumen. An example of this effort is shown in Figure 5-8, where the edges of the
lumen were expanded and the edges of the tumor were drawn in on the posterior side.

Figure 5-8: Final completion of the contour by manual adjustment of edges with eraser
tool. The red arrows show points where the contour from Figure 5-7 was adjusted.
For further information about ImageI, please contact Dr. Jingfei Ma at the following
email address: jma@mdanderson.org.
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5.4

Diffusion Image Artefacts

5.4.1 Flashing Artefacts / Single Slice Signal Drop Out

Figure 5-9: Massive shift of tumor signal on a single slice due to motion, causing a
“flashing” effect when slices are scrolled through quickly. This is caused large scale
motion or by parallel imaging correction failure, which leads to wrap-around artefacts
in the phase direction (middle image).
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5.4.2 T2 Shine-through

Figure 5-10: This is an example of T2 shine-through in the b200 image (a) and ADC map
(b) of a MONO scan. In this scan, the cancerous area of the esophagus is labeled with a
red arrow and healthy stomach is labeled with a blue arrow. Although the stomach is not
cancerous and is not experiencing abnormal restriction of diffusion, its T2 is relatively
long, causing it to be bright on the diffusion image. The ADC map accounts for T2 shinethrough, which is why the enhanced stomach on the diffusion image does not match with
an area of low ADC (darker) on the ADC map.

5.5

Comparison of Diffusion Parameter Measurements between Alternate

Groupings of <1% Viable Cell Patients
Comparison between ΔADC mean at interim from MONO scans is shown in Figure
5-11. It is seen that patients with <1% viable cell pathology have distinct diffusion behavior
from that of 0% viable cells.
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Figure 5-11: Comparison of ΔADC mean at interim between an alternate set of viable
cell groupings. The 27.7% cutoff between pCR and non-pCR is shown as a dotted line.

5.6

Padhani et al. ADC Method Comparison
In this section of the appendix, two methods of calculating mono-exponential ADC are

compared to the non-linear LMS (b0, b200, and b800) used in this paper: direct solution by
Padhani et al method (b200 and b800), and classic single b-value solution method (b0 and
b800). These comparisons are made for mean volume ADC, both as individual measurements
and relative change at IM. On average, mean volume ADC by Padhani et al. method was 42%
lower than the estimate by LMS used in this thesis. This is an intuitive finding, as exclusion of
b0 images would avoid perfusion effects at low b-value from propagating into the model.
Adding b0 images forces the curve fitting to account for loss in signal due to perfusion,
increasing ADC to account it. On average, mean volume ADC by the classic single b-value
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method (b0, b800) was 5.2% lower than the estimation method of this paper. This is driven by
the same mechanism, where inclusion of b200 images in this paper’s estimation method forces
ADC to account for fast drop in signal at b200 due to perfusion effects in lower b-value ranges.
Plots depicting correlation of the alternate methods with the method of this paper by linear
regression can be found in Figure 5-12.

Figure 5-12: Correlation of LMS Curve Fitting Method Mean ADC across all MONO
Scans with Mean ADC by Alternate Methods of ADC Estimation. R2 values from linear
regression are shown at the top.
Differences in estimated mean volume ADC between any two methods were not
different for any scan time-point (BL vs IM vs FU: KW test p-value >0.3 for either comparison)
and was also not different between pCR and non-pCR groupings (MW p-value >0.12 for both
comparisons). This implies that the differences were systematic. For separation of pCR and
non-pCR groupings, AUC=1 was maintained for only the curve fitting and 0,800 methods. The
method by Padhani et al. decreased AUC to 0.893. It is possible that a larger patient dataset
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may favor one method of ADC estimation over the others for the purpose of predicting
response in esophageal cancer. For this study, there is no sufficient evidence indicating
favorability of one estimation technique over another.

5.7

Comparison of Largest Slice and Single Slice Contour Measurements
If isolating the largest slice from a volume contour was a good approximation of

measurements by single slice contouring, mean ADC extracted from largest slice should
correlate well with mean ADC from single slice contouring. This was compared individually
for each of the readers in the inter-reader study. This correlation can be seen in Figure 5-13.
Measurements of ADC mean by single slice contouring did not correlate well with
measurement of ADC mean by largest slice according to linear regression This analysis is
highly simplified for purpose of comparing measurement techniques (Bland-Altman analysis
would be the proper method), but is enough to show that these techniques do not obtain
comparable measurements in this application (across all readers: max R2 = 0.6162, min R2 =
0.2887)
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Figure 5-13: Correlation of ADC mean measurements by Largest Slice (y-axis) and Single
Slice (x-axis) methods. Graphs are titled with their respective readers, and R2 values are
shown at the top of the graphs.
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5.8

Correlation of IVIM D and MONO ADC
Because both ADC from MONO scans and D from IVIM scans are parameters to

estimate the true diffusion coefficient, these parameters were compared. D from IVIM was
compared with LMS MONO ADC and Padhani et al. MONO ADC. Volume mean D by
IVIM was, on average, 41.5% lower than volume mean ADC by MONO with LMS fitting
and 21.1% lower than volume mean ADC by MONO with the Padhani et al. method. A
correlation of diffusion coefficient estimations is shown below in Figure 5-14.

Figure 5-14: Correlation of Volume Mean D by IVIM with Volume ADC Mean by
MONO through two different estimation methods. “LMS” corresponds to the MONO
ADC method used in this paper, while “200 800” corresponds with the method put forth
by Padhani et al. R2 values from linear regression are shown at the top.
MONO ADC by the Padhani et al. method correlates better with D by IVIM. Neither
of the ADC by MONO estimation methods were highly correlated with D by IVIM.
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